Coronary atherosclerosis

I9_CORATHER

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I24, I25, T82.2, Z95.1 Hospital discharge: ICD-9 — 414\|9960A Hospital discharge: ICD-8 — 414 Hospital discharge: excluded ICD-10 — I25.3 Cause of death: ICD-10 — I24, I25, T82.2, Z95.1 Cause of death: ICD-9 — 414\|9960A Cause of death: ICD-8 — 414 Cause of death: excluded ICD-10 — I25.3 2 out of 7 registries used, show all original rules.	65100
4. Check minimum number of events None	65100
5. Include endpoints None	65100
6. Filter based on genotype QC (FinnGen only)	65100

Control definitions (FinnGen only)

Control exclude: I9_ISCHHEART

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	I9_CORATHER
CONTROL_EXCLUDE	I9_ISCHHEART
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I25\|I24\|Z951\|T822
HD_ICD_9	414\|9960A
HD_ICD_8	414
HD_ICD_10_EXCL	I253
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I25\|I24\|Z951\|T822
COD_ICD_9	414\|9960A
COD_ICD_8	414
COD_ICD_10_EXCL	I253
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Coronary atherosclerosis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	657584	279386	367876
Only index persons	436363	184909	251454
Unadjusted period prevalence (%)
Whole population	9.32	8.00	10.28
Only index persons	8.41	6.80	9.60
Median age at first event (years)
Whole population	72.88	77.44	69.41
Only index persons	71.32	76.17	67.74

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	65100	20508	44592
Unadjusted period prevalence (%)	15.67	6.99	19.66
Median age at first event (years)	68.51	69.97	67.83

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
14338: Matched controls
117351

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

A10BA02

ATC

metformin; oral

2.4

323.0

4255

17786

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

1152.4

323.0

1513

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

31.5

323.0

8622

5372

I21.11

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

323.0

619

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

29.1

323.0

1674

531

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

+∞

323.0

594

TPH07

NOMESCO Finland

Cathetrisation of artery

3.6

323.0

1901

4841

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

532.8

323.0

8072

283

AA1

Conventional CABG

+∞

323.0

362

I20.01

ICD-10 Finland

Unstable angina

2916.3

323.0

1021

XF404

NOMESCO Finland

Ambulatory ECG

3.6

323.0

1739

4330

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

+∞

323.0

791

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

168.0

323.0

994

Angiography of the heart and coronary arteries

27.8

323.0

1244

399

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

496.6

323.0

356

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

+∞

323.0

468

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.7

323.0

4412

16595

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

236.9

323.0

1218

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

171.3

323.0

1517

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

7.0

323.0

1380

1766

I48

ICD-10 Finland

Atrial fibrillation and flutter

3.0

323.0

2601

8167

I25.2

ICD-10 Finland

Old myocardial infarction

1891.6

323.0

2391

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

4.8

323.0

2189

4236

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1878.5

323.0

1700

I21.19

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

3494.5

323.0

423

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

63.1

323.0

10048

4192

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.7

323.0

3644

13119

AN3

Balloon angioplasty and metallic stent

+∞

323.0

861

AN2

Balloon angioplasty, including several vessels

+∞

323.0

722

C03CA01

ATC

furosemide; systemic

3.9

323.0

4395

11920

A02BC02

ATC

pantoprazole; systemic

2.1

323.0

9877

60656

C08CA01

ATC

amlodipine; oral

2.6

323.0

5867

25020

A10AE04

ATC

insulin glargine; parenteral

3.8

323.0

1829

4302

C07AB02

ATC

metoprolol; systemic

3.1

323.0

3263

10137

C03DA01

ATC

spironolactone; oral

3.8

323.0

1783

4245

I10

ICD-10 Finland

Essential (primary) hypertension

3.0

323.0

9623

47491

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

1811.0

323.0

1070

FN2CA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), treating more than one main trunk during a single procedure

1782.3

323.0

439

205

Kela drug reimbursment

Chronic hypertension

2.7

323.0

4233

15662

C07AB07

ATC

bisoprolol; oral

8.1

323.0

10662

30989

C09AA05

ATC

ramipril; oral

4.9

323.0

5390

12760

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

237.1

323.0

1932

C10AX09

ATC

ezetimibe; oral

9.8

323.0

4259

4846

AN1

Coronary angiography

34.0

323.0

4299

1460

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

210.9

323.0

3143

156

C01DA14

ATC

isosorbide mononitrate; oral

58.2

323.0

4487

913

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

5.5

323.0

1458

2359

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

11.2

323.0

4157

4137

C10AA01

ATC

simvastatin; oral

3.9

323.0

8248

30158

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

2523.4

323.0

608

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.1

323.0

7744

32351

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

323.0

448

AN4

Balloon angioplasty and drug eluding stent

+∞

323.0

1422

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

+∞

323.0

371

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

3.8

323.0

1741

4124

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

16.1

323.0

961

522

I20.90

ICD-10 Finland

Angina pectoris, unspecified

300.0

323.0

769

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

5.8

323.0

4162

7725

WX872

NOMESCO Finland

Intensive care

7.4

323.0

1291

1554

B01AC04

ATC

clopidogrel; oral

19.9

323.0

5451

3504

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

6186.7

323.0

2538

I25

ICD-10 Finland

Chronic ischaemic heart disease

137.6

323.0

1640

110

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

7.5

323.0

885

1021

I20.00

ICD-10 Finland

Unstable angina

1340.7

323.0

760

R07.4

ICD-10 Finland

Chest pain, unspecified

5.6

323.0

6872

16466

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

13.6

323.0

1091

705

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

4286.1

323.0

3329

I20.99

ICD-10 Finland

Angina pectoris, unspecified

165.1

323.0

1893

108

I50.9

ICD-10 Finland

Heart failure, unspecified

6.9

323.0

1859

2469

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

323.0

730

103

Kela drug reimbursment

Diabetes, insulin-treated

2.8

323.0

4569

16801

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

+∞

323.0

1631

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

5.2

323.0

3400

6617

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

+∞

323.0

1298

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

+∞

323.0

341

B01AC24

ATC

ticagrelor; oral

9694.5

323.0

2053

280

Kela drug reimbursment

Clopidogrel

1607.3

323.0

365

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

6.4

323.0

5648

10814

201

Kela drug reimbursment

Chronic cardiac insufficiency

8.9

323.0

780

757

XF402

NOMESCO Finland

ECG with work load test

5.7

323.0

3091

5360

XF400

NOMESCO Finland

ECG with 12 standard connections

3.0

323.0

2770

8679

R06.0

ICD-10 Finland

Dyspnoea

3.1

323.0

4399

14762

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

3.4

323.0

4081

12237

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

4.7

323.0

1327

2484

C10AA05

ATC

atorvastatin; oral

6.7

323.0

9490

26575

Single vessel balloon catheter extension

+∞

323.0

438

B01AA03

ATC

warfarin; systemic

3.2

323.0

2417

7081

C10AA07

ATC

rosuvastatin; oral

3.7

323.0

5775

17971

I50.0

ICD-10 Finland

Congestive heart failure

8.5

323.0

859

870

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

+∞

323.0

2099

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

+∞

323.0

1935

K76

ICPC

Ischaemic heart dis without angina

90.8

323.0

747

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

871.7

323.0

514

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2558.0

323.0

12517

294

I20.09

ICD-10 Finland

Unstable angina

372.0

323.0

1802

I50.1

ICD-10 Finland

Left ventricular failure

11.2

323.0

814

626

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

3.8

322.1

1550

3620

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

9.1

321.8

739

698

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

4.1

317.5

1415

3084

T90

ICPC

Diabetes non-insulin dependent

2.3

315.7

3663

15110

WX892

NOMESCO Finland

Monitored bed care

4.0

310.7

1410

3122

207

Kela drug reimbursment

Chronic arrhythmias

3.2

306.6

1874

5274

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

382.3

297.0

321

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.2

295.2

4041

17914

A11

ICPC

Chest pain NOS

3.7

294.4

1438

3389

R07.3

ICD-10 Finland

Other chest pain

3.2

294.1

1752

4829

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

2446.5

288.7

301

C10AA04

ATC

fluvastatin; oral

3.7

287.3

1432

3429

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

282.3

292

Z50.0

ICD-10 Finland

Cardiac rehabilitation

79.2

280.4

340

I20.91

ICD-10 Finland

Angina pectoris, unspecified

486.6

272.3

292

C10AA03

ATC

pravastatin; oral

3.9

269.9

1266

2872

SPAT1262

SPAT

Handing over of treatment supplies

2.4

267.4

2800

10842

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

3.0

266.0

1783

5315

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

5.3

265.4

895

1455

K84

ICPC

Heart disease other

10.1

263.8

569

477

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

5.9

259.6

799

1162

N02AX02

ATC

tramadol; systemic, rectal

1.9

259.5

6449

35678

K74

ICPC

Ischaemic heart dis with angina

44.1

257.7

342

AP1

Catheterization of the left side of the heart

22.8

249.7

388

143

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

4.2

248.6

1063

2211

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.9

248.4

1162

2622

A10AE05

ATC

insulin detemir; parenteral

4.2

247.4

1038

2120

FN2CB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary chronic total occlusion

+∞

246.4

255

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

5.4

238.3

784

1235

A10AA02

ATC

6.1

236.4

707

989

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

1036.2

236.2

249

SPAT1097

SPAT

Recording of ECG

2.4

230.2

2274

8472

A10AA01

ATC

6.3

228.5

666

900

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

228.0

3079

13308

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.7

227.6

1860

6237

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.9

221.7

1515

4543

N02BE01

ATC

paracetamol; systemic, rectal

2.1

221.6

12336

87534

I21.10

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

219.3

227

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

217.7

4198

20854

FN1CA

NOMESCO Finland

Optical coherence tomography of coronary arteries

325.5

216.9

236

FN2AA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), balloon only

+∞

206.7

214

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

5.2

205.1

703

1158

FN1BE

NOMESCO Finland

Ultrasound examination of coronary arteries through catheter

207.9

202.1

225

AA1AD

NOMESCO Finland

CT of head and brain

2.0

201.9

3187

14591

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

4.2

198.9

847

1746

FL1AC

NOMESCO Finland

Left cardioangiography

19.5

196.4

320

137

C09AA02

ATC

enalapril; systemic

2.1

195.8

2648

11356

I35.0

ICD-10 Finland

Aortic (valve) stenosis

5.1

192.7

667

1110

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

5.6

189.2

606

921

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

5.3

187.6

629

1009

A10BK03

ATC

empagliflozin; oral

2.8

186.6

1330

4074

R4110

NOMESCO Finland

Physiotherapy

1.8

184.9

3998

20426

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

4.9

184.5

667

1164

ANC

Coronary artery pressure measurement (FFR, fractional flow reserve)

40.6

181.2

244

I20

ICD-10 Finland

Angina pectoris

16.5

178.3

308

156

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

18.4

177.5

295

134

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

87.2

175.3

210

H3603, E103

ICD-10 Finland

11.6

174.8

350

252

Coronary artery bypass surgery

+∞

174.7

181

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

9.3

173.9

392

355

FN1XT

NOMESCO Finland

Other coronary artery procedure through catheter

260.6

172.9

190

FNE20

NOMESCO Finland

Coronary bypass using free arterial graft of radial artery

+∞

170.9

177

R03AC02

ATC

salbutamol; inhalant

1.6

169.4

7291

45389

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.1

169.4

2276

9666

C08CA13

ATC

lercanidipine; oral

2.2

169.1

1938

7665

C08DB01

ATC

diltiazem; oral

4.5

167.8

655

1237

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.9

167.2

766

1682

R02

ICPC

Shortness of breath/dyspnoea

2.4

166.9

1653

6086

SPAT1249

SPAT

Treatment-related counselling outside office

1.7

166.1

5173

29383

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

5.1

164.9

571

949

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.8

163.8

3787

19627

FN2CC

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of left main trunk

711.4

162.0

172

I21.21

ICD-10 Finland

Acute transmural myocardial infarction with another location stenosed coronary artery

+∞

161.2

167

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.9

160.5

1092

3234

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.1

159.8

2251

9726

T89

ICPC

Diabetes insulin dependent

3.8

159.1

738

1637

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

6.5

159.0

451

585

I42.0

ICD-10 Finland

Dilated cardiomyopathy

5.7

157.3

492

725

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

12.8

157.0

300

195

TK800

NOMESCO Finland

Hemodialysis

5.7

155.5

486

715

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

19.6

155.1

252

107

B01AC06

ATC

acetylsalicylic acid; oral (platelet aggregation inhibitors excl. heparin)

64.1

154.9

193

FN1AD

NOMESCO Finland

CT of coronary arteries

6.8

154.3

424

526

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

4.1

153.5

666

1391

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

6.2

152.5

447

606

I21.4

ICD-10 Finland

Acute subendocardial myocardial infarction

198.7

150.6

168

C09CA01

ATC

losartan; oral

1.8

147.7

3433

17714

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

5.1

146.0

507

844

I20.9

ICD-10 Finland

Angina pectoris, unspecified

22.0

145.7

228

SPAT1263

SPAT

Sampling

1.6

143.7

5351

31555

R07.2

ICD-10 Finland

Precordial pain

6.0

143.6

433

609

C01AA05

ATC

digoxin; systemic

4.0

143.4

630

1330

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.6

142.6

1187

3964

A10BH01

ATC

sitagliptin; oral

2.4

141.7

1360

4904

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

4.3

140.8

575

1133

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

68.3

140.2

173

XFE00

NOMESCO Finland

Epicardial ultrasonography

5.9

139.3

422

597

294

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

1228.0

138.8

146

C08CA02

ATC

felodipine; oral

2.5

138.5

1188

4030

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.5

133.6

1135

3827

R53

ICD-10 Finland

Malaise and fatigue

1.9

132.8

2340

10939

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.7

132.4

1017

3234

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.7

132.4

1017

3235

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

5.5

132.2

423

640

A10BB12

ATC

glimepiride; oral

3.1

131.8

796

2165

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

131.4

2452

11694

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

129.5

5306

31811

R03BB04

ATC

tiotropium bromide; inhalant

2.4

129.4

1247

4496

G47.3

ICD-10 Finland

Sleep apnoea

1.7

127.9

3298

17432

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

8.6

127.8

299

289

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

10.8

127.7

264

203

C01BD01

ATC

amiodarone; systemic

5.0

127.4

445

745

Catheterization and pressure measurement of the left side of the heart

20.9

127.2

202

H02AB06

ATC

prednisolone; systemic

1.5

125.9

6203

38790

3015

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

94.8

125.7

149

WX720

NOMESCO Finland

Own respiration

3.5

124.9

651

1586

SPAT1310

SPAT

Counselling related to known health issue

1.6

124.8

4083

23044

N18.8

ICD-10 Finland

Other chronic renal failure

5.4

124.4

408

636

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.8

124.3

2815

14280

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

2.8

124.3

902

2768

I20.0

ICD-10 Finland

Unstable angina

34.1

124.1

173

B01AC22

ATC

prasugrel; oral

93.5

123.8

147

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

5.2

123.7

421

685

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

2.2

123.3

1398

5449

B01AF02

ATC

apixaban; oral

2.5

122.9

1094

3778

N03AX16

ATC

pregabalin; oral

1.7

122.6

3394

18277

C07AG02

ATC

carvedilol; oral

2.9

121.9

817

2383

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.1

121.2

1619

6778

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

120.1

3701

20510

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

11.8

118.8

235

165

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

117.7

1420

5686

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.1

117.5

505

1043

SPAT1301

SPAT

No procedures

1.6

116.1

3784

21251

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

115.9

2341

11414

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

19.1

115.6

189

A02BC01

ATC

omeprazole; systemic

1.6

115.6

3570

19758

Z49.1

ICD-10 Finland

Extracorporeal dialysis

6.9

115.2

311

376

C02AC05

ATC

moxonidine; oral

3.1

115.0

687

1852

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

114.9

1738

7640

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

6.9

114.8

310

375

I21.39

ICD-10 Finland

Acute transmural myocardial infarction with unspecified localization unspecified coronary artery status

998.0

114.7

121

R55

ICD-10 Finland

Syncope and collapse

2.3

114.5

1235

4695

M04AA01

ATC

allopurinol; systemic

2.2

114.2

1316

5158

TFP20

NOMESCO Finland

Cardiodefibrillation

2.7

113.6

891

2861

NHQ40

NOMESCO Finland

Amputation of toe

7.8

113.4

283

304

XCK10

NOMESCO Finland

Photography of fundus of eye

2.2

112.5

1340

5329

I47.2

ICD-10 Finland

Ventricular tachycardia

6.0

111.7

332

458

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

6.6

111.1

310

393

J01FF01

ATC

clindamycin; systemic

1.6

111.0

3801

21569

R42

ICD-10 Finland

Dizziness and giddiness

1.7

110.8

2634

13500

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

7.2

110.7

290

336

I24.9

ICD-10 Finland

Acute ischaemic heart disease, unspecified

170.6

110.1

124

C03AA03

ATC

hydrochlorothiazide; oral

2.2

109.6

1297

5140

I20.10

ICD-10 Finland

Angina angiospastic

481.5

109.1

117

M79.6

ICD-10 Finland

Pain in limb

1.5

108.0

4773

28780

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

107.9

4434

26281

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

7.6

107.1

270

295

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

106.9

5523

34474

UJF32

NOMESCO Finland

Coloscopy

1.6

106.7

3345

18515

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.0

106.5

1590

6939

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

8.9

105.8

243

228

FXZ00

NOMESCO Finland

Off-pump cardiac operation

51.0

105.6

136

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

105.2

6428

41551

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

3.3

105.2

587

1503

FNC40

NOMESCO Finland

Aorto-coronary venous bypass with four distal anastomoses

+∞

105.1

109

N03AX12

ATC

gabapentin; oral

1.8

105.0

2164

10585

A10AE06

ATC

insulin degludec; parenteral

3.6

104.7

527

1247

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

6.1

103.8

307

421

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

3.6

103.7

520

1227

A02BC05

ATC

esomeprazole; systemic

1.5

103.5

5697

35968

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

13.9

103.4

190

113

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

103.3

2874

15377

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

236.3

103.3

114

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

8.4

102.2

242

239

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.8

101.6

2027

9800

D64.9

ICD-10 Finland

Anaemia, unspecified

2.3

100.9

1019

3741

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

100.9

3775

21797

L04AA06

ATC

mycophenolic acid; systemic

4.4

100.8

393

739

127

Kela drug reimbursment

Transplant complication

4.9

100.5

359

616

K01

ICPC

Heart pain

8.3

100.2

239

H25.1

ICD-10 Finland

Senile nuclear cataract

1.7

99.4

2239

11244

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.5

99.3

845

2838

K78

ICPC

Atrial fibrillation/flutter

2.8

98.8

700

2110

S18

ICPC

Laceration/cut

1.5

98.8

5369

33701

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

16.1

96.3

167

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

96.0

2206

11135

C09DX04

ATC

valsartan and sacubitril; oral

14.1

95.3

174

102

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

9.8

95.1

206

174

XF600

NOMESCO Finland

Bloodpressure measurement

2.5

94.7

816

2759

C09CA03

ATC

valsartan; oral

2.1

93.9

1244

5160

SPAT1254

SPAT

Administration of medicine

1.9

93.5

1502

6718

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

6.9

93.4

250

299

J01DB01

ATC

cefalexin; oral

1.5

93.1

11197

82172

I21.29

ICD-10 Finland

Acute transmural myocardial infarction with other localization unspecified coronary artery status

806.7

92.6

C10AX13

ATC

evolocumab; parenteral

62.7

91.5

114

FNE21

NOMESCO Finland

Coronary bypass using free arterial graft of radial artery sequential

+∞

90.6

SPAT1104

SPAT

Monitoring of emergency patient

2.4

90.6

876

3144

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

90.5

1876

9153

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

8.9

90.5

207

193

H3601, E103

ICD-10 Finland

7.4

90.4

231

258

A12BA01

ATC

potassium chloride; oral

3.6

90.4

451

1059

A12AA04

ATC

calcium carbonate; oral

5.4

90.2

294

455

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

14.6

90.0

162

A02BA02

ATC

ranitidine; systemic

1.6

89.8

2540

13583

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

3.9

89.7

407

882

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

10.4

89.4

188

150

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.7

89.3

662

2049

177

Kela drug reimbursment

Insulin glargine 300 U / ml

4.2

89.3

371

742

A11CC03

ATC

alfacalcidol; systemic

4.2

89.2

370

739

Z94.0

ICD-10 Finland

Kidney transplant status

5.7

88.4

273

396

I50

ICD-10 Finland

Heart failure

5.9

88.0

264

369

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

4.2

87.7

361

716

A02BC03

ATC

lansoprazole; oral

1.5

87.6

3930

23506

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

5.5

87.4

278

418

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.5

87.1

754

2553

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

3.5

87.1

437

1031

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

3.8

86.6

396

864

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.6

86.6

697

2266

H3603, E113

ICD-10 Finland

9.7

86.5

188

160

H04AA01

ATC

glucagon; nasal, parenteral

4.2

86.3

357

711

FN2EC

NOMESCO Finland

Transcatheter coronary thrombectomy

381.6

86.1

B03XA02

ATC

darbepoetin alfa; parenteral

4.8

86.1

310

537

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

6.6

86.0

237

296

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

85.9

1400

6284

137

Kela drug reimbursment

Uraemia requiring dialysis

7.9

85.8

211

222

I49.3

ICD-10 Finland

Ventricular premature depolarization

2.3

85.6

907

3402

K02

ICPC

Pressure/tightness of heart

4.0

85.3

368

762

H43.1

ICD-10 Finland

Vitreous haemorrhage

3.8

85.2

392

860

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.9

85.0

561

1614

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.7

84.8

646

2034

PE1AT

NOMESCO Finland

Femoral artery PTA

9.8

84.7

183

154

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

15.2

84.2

149

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.4

84.0

445

1096

FNA20

NOMESCO Finland

Anastomosis to coronary arteries from bilateral internal mammary arteries

+∞

83.9

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

6.5

82.9

231

293

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

7.8

82.6

205

219

R11

ICD-10 Finland

Nausea and vomiting

2.2

82.3

926

3569

AA2

Off pump CABG sternotomy

+∞

82.0

ANE

Coronary internal ultrasound (IVUS)

360.8

81.3

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

13.0

81.2

153

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

81.2

3680

21984

H3600, E103

ICD-10 Finland

6.1

81.0

238

324

E66.00

ICD-10 Finland

Metabolic syndrome

2.3

80.4

839

3121

C09AA04

ATC

perindopril; oral

2.5

80.1

671

2230

I21.91

ICD-10 Finland

Myocardial infarction (acute) UNS stenosed coronary artery

698.9

80.1

FNG10

NOMESCO Finland

Embolectomy of coronary artery

+∞

80.0

N18.0

ICD-10 Finland

End-stage renal disease

6.6

79.8

220

275

SPAT1325

SPAT

Vaccination

1.5

79.1

3698

22213

FNA02

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, two distal anastamoses

+∞

79.1

FN2DB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary restenosis

+∞

79.1

C08CA05

ATC

nifedipine; systemic

2.5

79.0

682

2305

SPAT1260

SPAT

Consultation of another employee

1.6

78.9

2154

11362

S97

ICPC

Chronic ulcer skin

2.6

78.9

638

2079

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

78.4

1140

4894

C10BA02

ATC

simvastatin and ezetimibe; oral, topical

5.7

78.3

243

355

ANB

Coronary thrombectomy

+∞

78.1

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

6.0

77.6

230

317

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

77.3

2066

10830

L17

ICPC

Foot/toe symptom/complaint

1.5

77.2

3097

17969

A10BK01

ATC

dapagliflozin; oral

2.4

77.2

705

2454

K92

ICPC

Atherosclerosis/periph vascular dis

7.6

76.5

192

209

Z49.2

ICD-10 Finland

Other dialysis

8.5

76.1

178

173

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

75.6

2022

10594

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

75.5

1241

5573

B05DA

ATC

Isotonic solutions

8.3

75.5

179

178

A46

ICD-10 Finland

Erysipelas

1.7

75.5

1642

8099

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

6.0

75.3

223

307

V03AE01

ATC

polystyrene sulfonate; oral

6.6

75.3

207

258

C02EA02

ATC

3.4

75.0

392

955

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

5.1

75.0

253

408

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

75.0

1407

6618

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.6

74.9

2579

14420

M10.9

ICD-10 Finland

Gout, unspecified

2.5

74.8

640

2151

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.5

74.6

635

2125

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

74.6

1272

5787

J01MA12

ATC

levofloxacin; systemic

1.6

74.2

2193

11798

C09BA02

ATC

enalapril and diuretics; systemic

2.1

74.1

976

4025

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

73.9

5108

33038

B01AB05

ATC

enoxaparin; parenteral

1.5

73.9

3793

23166

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

13.7

73.8

136

K29

ICPC

Cardiovascular sympt/complt other

2.8

73.7

525

1585

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

+∞

73.3

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.2

73.2

842

3276

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.2

72.7

796

3025

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

7.1

72.3

189

219

V03AE02

ATC

sevelamer; oral

10.3

71.8

151

121

CKC15

NOMESCO Finland

Panretinal photocoagulation

8.7

71.7

165

156

H36.01

ICD-10 Finland

Diabetic maculopathy

5.9

71.5

214

299

R04.0

ICD-10 Finland

Epistaxis

2.2

71.1

775

2938

H3601, E113

ICD-10 Finland

5.8

71.1

218

314

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

5.8

70.9

217

312

I20.8

ICD-10 Finland

Other forms of angina pectoris

49.9

70.7

FM1CR

NOMESCO Finland

Heart perfusion PET with TT

18.4

70.5

116

I20.19

ICD-10 Finland

Angina angiospastic

616.0

70.5

K22

ICPC

Risk factor cardiovascular disease

2.3

70.2

688

2479

K77

ICPC

Heart failure

6.7

70.1

192

238

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.9

70.1

313

669

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

6.3

70.0

199

260

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.1

69.8

876

3538

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.2

69.2

764

2915

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

6.9

69.2

185

222

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

6.8

69.1

187

228

R51.80

ICD-10 Finland

Headache

1.7

68.8

1721

8826

J01MA02

ATC

ciprofloxacin; systemic

1.4

68.6

4627

29683

C09CA06

ATC

candesartan; oral

1.5

68.3

2844

16569

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

68.0

2275

12596

ZX120

NOMESCO Finland

Intravenous

1.9

68.0

1170

5334

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

68.0

2205

12114

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

5.5

67.9

217

329

PD5BD

NOMESCO Finland

Extensive CT of aorta

4.5

67.9

260

481

N02AA05

ATC

oxycodone; systemic

1.7

67.0

1518

7562

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

9.3

67.0

149

133

I49.5

ICD-10 Finland

Sick sinus syndrome

3.5

66.9

335

789

M48.0

ICD-10 Finland

Spinal stenosis

1.8

66.7

1402

6823

SPAT1081

SPAT

Cardiorespiratory global assessment

2.3

66.7

660

2389

E66.01

ICD-10 Finland

Obesity due to excess calories

1.9

66.6

1021

4460

N05CF01

ATC

zopiclone; oral

1.4

66.6

3981

24938

H36.00

ICD-10 Finland

Diabetic background retinopathy

5.0

66.6

231

385

Multi-vessel balloon catheter extension

+∞

66.5

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

66.3

1868

9896

PD5AD

NOMESCO Finland

CT of aorta

5.6

66.0

207

307

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

6.8

65.8

178

217

C10AA02

ATC

lovastatin; oral

3.2

65.8

382

1007

A10BB01

ATC

glibenclamide; oral

4.4

65.8

258

489

I44.2

ICD-10 Finland

Atrioventricular block, complete

5.0

65.6

228

381

A28

ICPC

Limited function/disability NOS

1.8

65.5

1262

5972

PD3AT

NOMESCO Finland

Pelvic artery PTA

13.5

65.4

121

C08CA07

ATC

nisoldipine; oral

14.6

65.4

117

EBA00

NOMESCO Finland

Extraction of tooth

1.4

65.2

4012

25249

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

7.8

64.9

160

170

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

5.1

64.6

220

359

CKC12

NOMESCO Finland

Photocoagulation of retina

2.3

64.1

619

2213

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

+∞

63.6

N06AX11

ATC

mirtazapine; oral

1.4

63.4

4006

25306

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

4.8

63.4

227

392

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

3.2

62.9

353

907

C07AB03

ATC

atenolol; systemic

2.4

62.7

601

2140

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

12.8

62.4

118

WX110

NOMESCO Finland

Local anesthesy

1.4

62.3

9097

65883

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

8.6

62.2

144

138

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

3.0

62.0

396

1114

K05.31

ICD-10 Finland

Periodontitis pronounced

1.7

61.7

1348

6632

J01AA02

ATC

doxycycline; systemic

1.4

61.6

10874

81198

I21

ICD-10 Finland

Acute myocardial infarction

116.8

61.4

A06AD11

ATC

lactulose; oral

1.7

61.4

1342

6604

M54.5

ICD-10 Finland

Low back pain

1.4

61.3

4128

26343

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

8.6

61.1

142

137

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

7.4

60.8

154

171

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

5.5

60.7

193

291

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

60.4

1834

9885

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.9

60.2

404

1175

R50.9

ICD-10 Finland

Fever, unspecified

1.7

60.0

1500

7673

J01DA01

ATC

[U] cefalexin; systemic

1.3

59.9

8139

58084

L28

ICPC

Limited function/disability (L)

1.6

59.7

1572

8159

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.4

59.4

306

738

A04

ICPC

Weakness/tiredness general

1.8

59.4

1204

5783

Z49.0

ICD-10 Finland

Preparatory care for dialysis

5.5

59.3

188

283

J01CA04

ATC

amoxicillin; systemic

1.4

58.9

10634

79276

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.8

58.9

1150

5458

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.8

58.8

1233

5985

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

58.8

1139

5393

4100X

ICD-9 Finland

Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]

+∞

58.8

XF640

NOMESCO Finland

3.1

58.6

351

946

CKC10

NOMESCO Finland

Local photocoagulation of retina

4.1

58.5

248

507

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.0

58.4

368

1028

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

6.2

58.3

169

227

A10BJ06

ATC

semaglutide; parenteral

2.4

58.0

514

1757

A10BH05

ATC

linagliptin; oral

2.6

57.9

458

1471

111

Conventional CABG

+∞

57.8

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.4

57.8

511

1747

SPAT1153

SPAT

Removal of sutures

1.4

57.5

3881

24711

PEN23

NOMESCO Finland

Plastic repair of femoral artery

9.6

57.2

124

106

N07BA03

ATC

varenicline; oral

2.0

57.0

766

3176

K80

ICPC

Cardiac arrhythmia NOS

1.9

56.8

898

3963

R2110

NOMESCO Finland

Giving the first information

2.0

56.7

820

3499

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

3.7

56.6

264

587

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

13.3

56.6

105

4019X

ICD-9 Finland

Essential hypertension, Unspecified

4.6

56.5

212

385

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.1

56.4

332

884

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

4.3

56.4

227

442

WX402

NOMESCO Finland

General anaesthesia

1.5

56.3

2153

12243

TFP34

NOMESCO Finland

Electrophysiological investigation

2.6

56.0

446

1437

SPAT1058

SPAT

PEF monitoring instruction

1.8

55.7

1024

4762

SPAT1255

SPAT

Intravenous administration of medicine

2.0

55.7

754

3135

J01FA06

ATC

roxithromycin; oral

1.3

55.7

5273

35451

SPAT1312

SPAT

General health counselling

1.4

55.7

3603

22744

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.6

55.7

1491

7763

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

55.2

1964

10976

FN2EA

NOMESCO Finland

Coronary rotablation

+∞

54.9

TKC20

NOMESCO Finland

Catheterisation of bladder

2.1

54.9

658

2598

K75

ICPC

Acute myocardial infarction

62.2

54.8

K99

ICPC

Cardiovascular disease other

3.3

54.8

295

737

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.0

54.4

233

481

TFN99

NOMESCO Finland

Catheterisation of heart with other coronary procedure

167.1

54.3

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

8.7

53.9

124

118

B05DB

ATC

Hypertonic solutions

7.5

53.8

135

148

WX002

NOMESCO Finland

Sedation and analgesia

1.5

53.4

2416

14226

A10AA03

ATC

7.7

53.3

132

142

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.4

53.0

494

1735

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.2

53.0

299

773

I47.1

ICD-10 Finland

Supraventricular tachycardia

2.3

52.7

532

1942

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

3.1

52.7

311

830

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

4.0

52.4

224

462

CJB10

NOMESCO Finland

Laser discission of secondary cataract

2.0

52.1

720

3017

C07AB08

ATC

celiprolol; oral

3.3

51.7

286

729

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

51.7

1364

7066

SPAT1098

SPAT

Exercise ECG

3.1

51.7

300

792

Z71.8

ICD-10 Finland

Other specified counselling

1.4

51.6

2653

16011

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

6.3

51.5

147

194

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

51.4

1338

6902

I21.12

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

450.6

51.3

R60.0

ICD-10 Finland

Localized oedema

1.7

51.3

1185

5913

J01MA14

ATC

moxifloxacin; systemic

1.7

51.0

1067

5168

H26.4

ICD-10 Finland

After-cataract

1.9

51.0

806

3553

L03

ICPC

Low back symptom/complaint

1.4

50.8

2859

17545

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

50.5

1573

8502

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

50.5

1402

7359

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

49.8

1368

7160

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

49.8

1488

7959

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

7.7

49.8

123

132

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

49.7

1410

7442

R00.2

ICD-10 Finland

Palpitations

1.8

49.7

880

4038

N05BA04

ATC

oxazepam; oral

1.4

49.6

2900

17910

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

49.6

897

4143

XFN00

NOMESCO Finland

Inside imaging of coronary arteries??

47.8

49.5

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.9

49.4

757

3300

I20.88

ICD-10 Finland

Other angina pectoris other occlusion in coronary artery

+∞

49.1

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.2

49.0

537

2039

N06AA09

ATC

amitriptyline; systemic

1.6

48.6

1340

7019

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

5.9

48.6

144

200

N19

ICD-10 Finland

Unspecified kidney failure

3.1

48.5

281

740

I44.7

ICD-10 Finland

Left bundle-branch block, unspecified

3.6

48.4

232

529

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

2.5

48.3

420

1421

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

48.0

1481

7980

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.5

48.0

244

584

J45.1

ICD-10 Finland

Nonallergic asthma

1.9

47.7

809

3654

N06AB04

ATC

citalopram; systemic

1.4

47.6

2684

16452

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

6.1

47.5

137

184

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

47.5

4127

27199

C08DA01

ATC

verapamil; systemic

2.3

47.4

468

1693

A10BX01

ATC

guar gum; systemic

2.6

47.2

380

1234

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

6.3

47.2

134

176

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

47.0

1229

6341

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

46.9

3082

19402

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

46.6

3298

21018

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.7

46.5

221

501

WW502

NOMESCO Finland

Autotransfusion

8.7

46.4

106

100

C10AB05

ATC

fenofibrate; oral

3.0

45.9

290

812

E87.5

ICD-10 Finland

Hyperkalaemia

4.7

45.9

166

291

XPX08

NOMESCO Finland

Intraoperative flow measurement

8.6

45.9

106

102

FM1TQ

NOMESCO Finland

Heart perfusion SPECT with low dose CT at rest and with exercise

14.8

45.8

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

3.5

45.6

231

551

P01AB01

ATC

metronidazole; oral, rectal

1.3

45.6

5092

34760

I21.0

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

401.0

45.6

A10BJ02

ATC

liraglutide; parenteral

2.6

45.4

351

1113

B01AC07

ATC

dipyridamole; systemic

3.5

45.4

227

536

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

5.9

45.3

134

186

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

45.0

987

4846

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

44.9

816

3773

V03AE03

ATC

lanthanum carbonate; oral

9.1

44.3

FN1LE

NOMESCO Finland

Mesurement of coronary artery reserve with iv vasodilatator

+∞

44.3

I21.02

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

44.3

WZC30

NOMESCO Finland

Teaching

1.5

44.2

1600

8947

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

44.2

1368

7372

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.1

43.8

559

2269

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

43.7

1392

7549

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

43.7

2027

11946

R00.1

ICD-10 Finland

Bradycardia, unspecified

3.1

43.5

259

696

A41.9

ICD-10 Finland

Sepsis, unspecified

2.6

43.4

339

1082

196

Kela drug reimbursment

Paricalcitol and cinacalcet

7.2

43.4

112

129

K92.1

ICD-10 Finland

Melaena

2.2

43.3

456

1700

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

43.3

6484

45950

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

43.2

952

4678

H36.09

ICD-10 Finland

Diabetic retinopathy (E10-E14+ with common fourth character .3)

9.8

43.1

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

43.0

2551

15742

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.2

43.0

484

1860

315

Kela drug reimbursment

Clopidogrel

6.4

42.9

120

155

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.2

42.8

488

1885

A10BD07

ATC

metformin and sitagliptin; systemic

2.1

42.8

538

2167

I21.20

ICD-10 Finland

Acute transmural myocardial infarction with other localization no detected stenosis of coronary artery

376.2

42.7

I42.1

ICD-10 Finland

Obstructive hypertrophic cardiomyopathy

8.4

42.5

C10BA06

ATC

rosuvastatin and ezetimibe; oral

5.2

42.5

140

222

FC1AC

NOMESCO Finland

Angiography of thoracal aortta

17.2

42.5

PEH56

NOMESCO Finland

Bypass from femoral to popliteal artery above knee

8.7

42.4

WX722

NOMESCO Finland

PEEP

2.0

42.2

575

2395

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.9

42.2

647

2819

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

7.5

42.1

105

115

GD1LA

NOMESCO Finland

4.3

42.0

167

323

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

5.2

41.9

139

222

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

5.0

41.9

143

236

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

41.9

691

3092

C02CA01

ATC

prazosin; oral

5.2

41.9

138

219

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

9.5

41.9

H02AB04

ATC

methylprednisolone; systemic

1.5

41.8

1807

10486

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

41.8

462

1761

L04

ICPC

Chest symptom/complaint

1.9

41.6

672

2984

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

8.2

41.6

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

7.3

41.6

106

120

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.7

41.5

986

4951

C07BB07

ATC

bisoprolol and thiazides; systemic

2.1

41.4

510

2037

H3600, E113

ICD-10 Finland

4.7

41.1

148

259

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.7

41.1

949

4724

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

40.8

809

3846

K02.1

ICD-10 Finland

Caries of dentine

1.3

40.7

7167

51671

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

40.6

945

4715

SPAT1053

SPAT

Memory test

1.6

40.5

1081

5600

SPAT1281

SPAT

Other administrative function

1.7

40.5

840

4050

25008

ICD-8 Finland

Diabetes mellitus, Complicatio alia definita

12.8

40.5

ZXA05

NOMESCO Finland

Left side

1.4

40.2

3012

19300

160

Kela drug reimbursment

exenatide

2.6

40.0

315

1012

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

39.9

1267

6859

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

39.9

1243

6700

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

10.0

39.8

B04AB02

ATC

6.5

39.8

110

140

ZXA00

NOMESCO Finland

Right side

1.3

39.6

3213

20834

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

39.4

7315

52989

C07AA07

ATC

sotalol; systemic

2.6

39.4

301

951

SPAT1285

SPAT

Provision of consultation response

2.0

39.3

570

2431

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

39.3

892

4417

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.8

39.2

757

3567

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

2.1

39.2

452

1755

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.5

39.1

340

1151

I42.2

ICD-10 Finland

Other hypertrophic cardiomyopathy

5.3

39.1

126

195

H03AA01

ATC

levothyroxine sodium; systemic

1.4

39.1

2909

18603

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.8

38.9

751

3540

I95.1

ICD-10 Finland

Orthostatic hypotension

3.0

38.8

239

659

2504B

ICD-9 Finland

Diabetes mellitus, Diabetes with renal manifestations[DIABETES MELLITUS CUM COMPLICATIONE OCULI ,TYYPPI I]

10.9

38.6

6480A

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Diabetes mellitus

4.9

38.6

134

226

FXG00

NOMESCO Finland

Insertion and use of IABP

33.5

38.4

WZA90

NOMESCO Finland

Other doctors statement

1.4

38.4

2718

17235

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

4.0

38.4

165

344

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

38.3

1235

6706

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

38.2

2756

17526

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

6.1

38.2

110

148

H28.0*E10.3

ICD-10 Finland

Other specified diabetes mellitus - Diabetic cataract

11.4

38.0

I21.1

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

334.9

37.9

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.4

37.9

336

1151

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.7

37.8

898

4505

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

37.7

1926

11531

K85

ICPC

Elevated blood pressure

1.5

37.6

1639

9514

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.6

37.6

451

6507

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

5.8

37.6

113

161

1CX08

NOMESCO Finland

11.0

37.4

WX890

NOMESCO Finland

Intesive care monitoring

6.7

37.4

100

122

K08.3

ICD-10 Finland

Retained dental root

1.7

37.3

817

4002

N06AX21

ATC

duloxetine; oral

1.5

37.2

1326

7371

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.9

37.1

239

679

N17

ICPC

Vertigo/dizziness

1.6

37.1

1096

5824

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.1

36.9

219

590

25002

ICD-8 Finland

Diabetes mellitus, Retinopathia diabetica

9.9

36.8

I48.1

ICD-10 Finland

Persistent atrial fibrillation

3.0

36.7

222

605

R03BA02

ATC

budesonide; inhalant

1.4

36.7

2002

12127

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

36.7

3217

21061

GD1AD

NOMESCO Finland

Thorax CT examination

2.0

36.6

491

2033

SPAT1252

SPAT

Overall medication plan or its review

1.8

36.6

638

2907

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

6.5

36.5

100

126

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.1

36.5

422

1642

K87

ICPC

Hypertension complicated

3.0

36.5

224

615

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

4.5

36.5

138

255

ZXA10

NOMESCO Finland

Bilateral

1.4

36.2

1977

11974

AS4

Physiological pacemaker insertion DDD (R)

5.1

36.2

122

199

C10AB02

ATC

bezafibrate; oral

4.7

36.2

131

231

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

36.2

3897

26257

PEH57

NOMESCO Finland

Bypass from femoral artery to popliteal artery below knee

9.7

36.1

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

5.9

36.0

106

147

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

35.9

2857

18425

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.7

35.9

785

3841

G44.2

ICD-10 Finland

Tension-type headache

1.5

35.9

1486

8532

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.3

35.8

368

1356

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.8

35.6

610

2765

C09AA01

ATC

captopril; oral

4.1

35.6

147

296

SPAT1216

SPAT

Assessment of functional ability

1.5

35.5

1357

7656

K24

ICPC

Fear of heart disease

2.5

35.4

289

947

R96

ICPC

Asthma

1.6

35.4

969

5050

C09AA03

ATC

lisinopril; oral

2.0

35.4

501

2119

2507B

ICD-9 Finland

Diabetes mellitus, Diabetes with peripheral circulatory disorders[DIABETES MELLITUS CUM COMPLICAT ALIA ,TYYPPI I]

13.8

35.4

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

6.1

35.4

102

138

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

35.3

9233

69205

R95

ICPC

Chron obstructive pulmonary disease

2.7

35.3

264

822

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

4.0

35.3

150

310

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

5.2

35.0

114

179

Z01.9

ICD-10 Finland

Special examination, unspecified

1.8

34.9

657

3071

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

34.9

1046

5578

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.8

34.8

595

2694

SPAT1229

SPAT

Assessment of need for aid

1.7

34.7

745

3625

TK810

NOMESCO Finland

Hemofiltration

5.2

34.7

114

181

4120B

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]

+∞

34.7

A07AA02

ATC

nystatin; oral

1.7

34.7

702

3359

N05BA01

ATC

diazepam; systemic, rectal

1.4

34.4

1581

9264

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.9

34.4

544

2395

SPAT1101

SPAT

Orthostatic test

2.2

34.3

360

1342

B03XA01

ATC

erythropoietin; parenteral

4.9

34.2

118

198

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

7.2

34.2

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.6

34.1

1045

5600

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

6.1

34.1

132

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.1

34.1

423

1697

J01EA01

ATC

trimethoprim; systemic

1.3

34.1

2661

17093

M10.0

ICD-10 Finland

Idiopathic gout

2.5

33.9

274

894

AQ1

Conventional electrophysiological examination

3.6

33.9

162

371

I79.2*E10.5

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

23.3

33.8

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

5.0

33.8

114

187

K28

ICPC

Limited function/disability (K)

3.3

33.7

184

467

WX870

NOMESCO Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4694

16595

1.95

323.31

5.1

3.5

5.9

5.8

kpa

1.91

4553

16160

(3002032) Base excess in Venous blood by calculation

4690

16587

1.95

322.70

5.1

3.5

1.8

1.9

mmol/l

2.14

3864

13651

(3018405) Lactate [Moles/volume] in Arterial blood

2238

5850

2.57

317.66

4.9

4.0

1.4

mmol/l

0.04

2196

5759

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

5396

20107

1.86

317.07

1.9

1.7

—

(3027945) Reticulocytes/100 erythrocytes in Blood

5548

20940

1.84

312.75

2.5

1.9

1.8

13.51

4946

18387

(3014111) Lactate [Moles/volume] in Serum or Plasma

4606

16397

1.93

309.95

8.8

6.8

1.4

1.3

mmol/l

3.43

4429

15837

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

18793

96222

1.56

307.65

9.7

6.4

1.2

mmol/l

151.64

15909

80617

(3019060) Gas panel - Arterial blood

4232

11244

2.62

307.65

5.8

4.5

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

7681

30395

1.81

307.65

3.9

3.4

0.8

mmol/l

0.87

7201

28210

(3009508) Creatinine [Moles/volume] in Urine

13960

60081

1.83

307.65

3.6

3.1

7.2

7.6

mmol/l

28.67

11760

49916

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

9056

37024

1.78

307.65

2.3

1.7

1.3

1.4

mg/l

2.13

7036

28731

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

6691

20432

2.37

307.65

8.7

7.1

5.0

5.1

kpa

13.19

6401

19549

(3016502) Oxygen saturation in Arterial blood

6200

18098

2.47

307.65

9.0

7.5

95.6

95.7

0.84

5984

17483

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2377

5949

2.69

307.65

3.7

2.8

0.3

0.4

u/ml

2.96

1510

3207

(3020682) Albumin/Creatinine [Ratio] in Urine

14463

61456

1.88

307.65

4.5

3.9

13.2

7.7

mg/mmol

22.21

9564

37946

(3032080) INR in Blood by Coagulation assay

19182

76207

2.38

307.65

13.2

7.9

1.4

1.2

inr

35.62

5482

20718

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3743

11399

2.25

307.65

10.6

8.9

1.4

1.34

3722

11328

(3003396) Base excess in Arterial blood by calculation

6679

20455

2.37

307.65

8.7

7.0

1.0

1.1

mmol/l

0.23

5294

16378

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

5715

14125

2.92

307.65

3.7

2.4

265.3

163.2

ng/l

35.28

5312

12781

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

14388

56539

2.09

307.65

2.6

2.1

221.3

213.9

u/l

0.35

13459

52845

(3014576) Chloride [Moles/volume] in Serum or Plasma

6447

23373

1.95

307.65

8.9

6.9

104.4

104.3

mmol/l

0.68

6278

22907

(3022217) INR in Platelet poor plasma by Coagulation assay

6964

24928

2.00

307.65

30.2

23.2

1.5

1.3

inr

8.81

913

3567

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

17042

51293

3.23

307.65

3.9

2.6

1872.8

1099.3

ng/l

57.12

15386

43100

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

10812

33745

2.54

307.65

6.0

2.9

1131.9

201.2

ng/l

20.29

9696

26508

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

10868

43247

1.90

307.65

2.6

2.2

3.1

3.0

mg/l

6.98

9488

36317

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

7419

29635

1.78

307.65

2.0

1.8

—

(3012516) Albumin [Mass/volume] in Urine

13886

58318

1.89

307.65

3.7

3.2

328.8

433.5

mg/l

2.08

9426

35856

(3044889) 12 lead EKG panel

24940

133140

1.73

307.65

6.0

3.5

—

(3027801) Oxygen [Partial pressure] in Arterial blood

6688

20421

2.37

307.65

8.7

7.1

11.8

12.5

kpa

24.67

6393

19532

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

18335

68716

2.52

307.65

5.6

3.0

151.5

31.3

ng/l

4.71

14292

48917

(3000991) Gas panel - Venous blood

4470

15393

2.00

307.65

10.6

8.1

—

(3012544) pH of Venous blood

5001

17095

2.03

307.65

5.2

3.5

7.4

1.20

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

7052

23782

2.14

307.65

3.5

2.4

20.5

23.2

50.67

5951

20210

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3256

9835

2.25

307.65

11.9

9.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

3942

10533

2.59

307.65

8.7

6.7

24.5

24.8

mmol/l

3.47

3728

9792

(3001122) Ferritin [Mass/volume] in Serum or Plasma

14338

68045

1.61

307.65

3.6

2.7

155.0

162.0

ug/l

1.48

13178

61886

(3020779) Urea [Moles/volume] in Serum or Plasma

5233

15800

2.34

307.65

10.9

6.6

11.2

9.7

mmol/l

32.95

5011

14989

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3769

11337

2.28

307.65

10.7

9.0

0.7

1.11

3747

11274

(3018677) aPTT in Platelet poor plasma by Coagulation assay

8579

27001

2.39

307.65

2.6

2.0

30.7

29.5

43.07

8377

26199

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

5417

19997

1.88

307.65

1.9

1.7

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

5715

16742

2.44

307.65

9.5

7.9

120.0

121.7

g/l

6.53

5531

16151

(3022948) Iron [Moles/volume] in Serum or Plasma

7858

27401

2.10

307.65

3.4

2.4

11.7

13.9

umol/l

2.39

7335

25209

(3004789) Transferrin [Mass/volume] in Serum or Plasma

7381

25363

2.11

307.65

3.4

2.3

g/l

0.86

6875

23297

(3024561) Albumin [Mass/volume] in Serum or Plasma

16669

83173

1.56

307.65

5.8

4.8

34.6

35.3

g/l

34.68

15539

76770

(3013826) Glucose [Moles/volume] in Serum or Plasma

23157

109326

2.09

307.65

6.9

4.4

7.2

6.7

mmol/l

125.49

22174

102485

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

17494

87856

1.57

307.65

8.7

5.7

1.2

mmol/l

136.82

16105

78805

(3023368) Bacteria identified in Blood by Culture

12025

51499

1.77

307.65

5.0

4.3

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

19726

98218

1.68

307.65

6.3

6.6

12.1

11.7

umol/l

4.09

18818

93036

(3014007) Fractional oxyhemoglobin in Arterial blood

3769

11454

2.26

307.65

10.8

9.0

93.8

94.0

0.89

3755

11421

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

6836

13278

3.88

307.65

2.9

1.9

10.4

5.9

ug/l

26.53

6163

11237

(3003458) Phosphate [Moles/volume] in Serum or Plasma

6273

24171

1.82

307.65

8.7

5.3

1.1

1.0

mmol/l

52.22

5915

22388

(3043409) Potassium [Moles/volume] in Arterial blood

1979

5017

2.64

297.86

5.3

4.2

3.9

mmol/l

9.07

1871

4725

(3020891) Body temperature

2445

6878

2.39

297.18

5.9

4.5

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

12157

58666

1.52

255.37

3.0

2.6

57.8

59.2

u/l

1.51

11300

53632

(3023520) Reticulocytes [#/volume] in Blood

4257

15816

1.84

247.32

2.6

2.7

72.2

68.5

e9/l

8.10

3296

11916

(3024354) Oxygen [Partial pressure] in Venous blood

3783

13544

1.90

246.36

4.1

2.9

4.7

4.6

kpa

1.27

3651

13132

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

16607

85868

1.47

245.19

4.8

3.9

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3212

11015

1.97

236.69

9.3

6.7

24.6

24.9

mmol/l

5.87

3187

10914

(3004119) Hemoglobin [Mass/volume] in Venous blood

3149

10738

1.98

235.74

4.5

2.9

123.6

130.1

g/l

41.02

3068

10515

(3047181) Lactate [Moles/volume] in Blood

1885

5301

2.37

227.62

7.4

5.5

1.4

1.3

mmol/l

1.88

1692

4672

(3018418) pH of Serum or Plasma

11700

57129

1.48

224.34

5.4

4.1

7.4

0.36

2443

10497

(3026008) Bacteria identified in Urine by Culture

11376

55237

1.49

224.24

3.7

3.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2310

7157

2.16

222.30

6.3

4.7

1.8

1.6

3.64

2167

6733

(3007930) Methemoglobin/Hemoglobin.total in Blood

2258

7020

2.15

215.22

6.5

4.7

0.9

1.75

2114

6603

(3026493) Urate [Moles/volume] in Serum or Plasma

10560

50851

1.49

214.58

3.2

2.6

3776.8

5000.7

umol/l

2.43

9085

43747

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

25752

146958

1.49

212.49

8.8

7.8

81.2

79.3

u/l

7.30

24447

137687

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

5374

22217

1.66

212.39

4.2

4.5

251.3

242.5

u/l

3.22

5066

20961

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2531

8320

2.04

208.53

1.7

1.6

g/l

1.76

2178

7060

(3019309) Folate [Moles/volume] in Red Blood Cells

7901

35986

1.54

207.83

1.9

1.7

1215.4

1144.3

nmol/l

8.46

6093

26491

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2885

10055

1.93

201.36

11.4

9.0

24.1

24.4

mmol/l

3.79

2665

9427

(4094501)

1711

4885

2.32

199.21

1.2

1.1

—

(3039000) Anion gap in Blood

1424

3740

2.52

198.25

8.2

6.4

11.4

11.1

mmol/l

2.17

1301

3377

(3018572) Chloride [Moles/volume] in Blood

1424

3740

2.52

198.25

8.2

6.4

105.1

104.9

mmol/l

0.63

1302

3377

(3000850) Epithelial cells [#/volume] in Urine

8456

39557

1.50

193.94

3.2

2.5

4.9

5.0

e6/l

0.21

7429

34419

(3031040) Bacteria [#/volume] in Urine by Automated count

21816

121546

1.42

192.46

5.5

4.4

1554.7

1392.7

e6/l

0.14

331

1753

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

316

261

7.87

185.36

8.6

7.7

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

11627

58286

1.43

184.59

3.4

3.3

39.6

34.8

u/l

2.57

10982

54981

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

15197

79921

1.40

183.40

2.2

2.0

93.8

95.6

pmol/l

4.44

8102

40814

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2043

6498

2.09

182.91

3.0

2.1

569.9

530.9

ug/l

0.15

1961

6097

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1268

3306

2.53

178.95

3.1

0.8

nmol/l

3.94

968

2555

(3004451) EKG impression Narrative

472

636

4.84

177.86

1.4

1.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

5011

21197

1.61

177.77

2.1

1.7

—

(3030467) Casts [#/volume] in Urine by Automated count

10665

53082

1.43

173.39

3.8

3.1

0.5

0.4

e6/l

3.43

8307

39431

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2465

8552

1.92

173.34

5.5

3.9

23.9

24.3

mmol/l

5.25

2176

7704

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2224

7490

1.98

170.25

2.1

2.0

2.1

2.3

ug/l

0.41

1999

6566

(3038071) Oxygen [Partial pressure] in Mixed venous blood

282

226

8.10

169.13

8.5

7.8

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1505

4364

2.28

168.63

2.7

2.3

149.7

95.9

ug/min

3.42

934

2515

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2408

8369

1.92

168.27

3.5

2.6

1.3

0.24

2399

8330

(3002582) Erythrocytes [#/volume] in Urine

11425

57840

1.41

167.22

3.9

3.2

83.7

87.9

e6/l

0.10

9085

43909

(3006315) Basophils [#/volume] in Blood

16912

91494

1.37

165.27

6.2

5.9

0.0

e9/l

6.28

14696

77989

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2777

10171

1.83

165.03

1.6

1.5

—

(36304419) Bacteria [Presence] in Urine

10293

51267

1.42

164.67

3.7

3.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

2438

8573

1.90

164.39

4.5

3.1

25.1

25.3

mmol/l

1.59

2359

8339

(3001604) Monocytes [#/volume] in Blood

16819

91004

1.37

163.48

6.2

5.9

0.6

e9/l

74.85

14581

77553

(3013115) Eosinophils [#/volume] in Blood

17347

94346

1.37

163.09

6.4

6.2

0.2

e9/l

19.92

15339

81494

(3019198) Lymphocytes [#/volume] in Blood

17165

93359

1.36

160.08

6.3

6.0

1.9

e9/l

2.14

15164

80928

(3042936) Bacteria identified in Isolate by Culture

5956

26831

1.52

158.67

2.5

2.0

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2340

8210

1.90

158.66

3.5

2.6

0.7

0.12

2250

7855

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1496

4452

2.22

157.55

3.6

2.9

24.5

24.9

mmol/l

2.31

1334

3873

(3021960) Folate [Moles/volume] in Serum or Plasma

9098

44644

1.42

156.47

1.7

1.5

19.4

20.7

nmol/l

12.55

7930

37423

(3018095) Leukocytes [#/volume] in Urine

12793

66590

1.38

155.52

4.4

3.7

106.8

100.9

e6/l

0.25

9665

47132

(3028626) Oxygen [Partial pressure] in Capillary blood

1314

3722

2.33

155.10

3.3

2.7

8.0

8.1

kpa

1.27

1238

3428

(3013650) Neutrophils [#/volume] in Blood by Automated count

19138

106244

1.36

153.75

8.6

9.6

4.5

4.1

e9/l

92.47

16821

91972

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4512

19237

1.59

152.86

4.3

3.3

—

(3006576) Bicarbonate [Moles/volume] in Blood

361

439

5.35

151.51

7.7

5.0

25.6

25.1

mmol/l

0.97

326

403

(3029937) Albumin [Presence] in Urine by Test strip

9612

47882

1.41

150.63

5.2

4.0

0.0

estimate

0.13

3099

15375

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

228

161

9.18

149.23

7.9

6.3

—

(3010421) pH of Blood

1504

4587

2.16

149.09

5.2

3.6

7.4

3.19

1325

3894

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3052

11853

1.72

148.06

4.4

3.4

5.1

5.2

kpa

3.20

2849

10887

(3027315) Oxygen [Partial pressure] in Blood

1364

4010

2.24

147.72

5.2

3.8

8.5

8.6

kpa

0.85

1338

3913

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3368

13452

1.68

147.47

1.7

1.6

—

(40767503) Oxygen content in Capillary blood by calculation

1306

3784

2.27

146.30

3.0

2.5

15.8

16.4

4.92

705

2007

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

29269

174974

1.48

146.09

8.5

5.8

43.4

39.8

mmol/mol

307.65

27438

159688

(3009343) pH of Capillary blood

3013

11702

1.72

146.05

4.4

3.4

7.4

3.37

492

1494

(3024928) Oxygen saturation in Venous blood

1283

3692

2.29

146.01

4.5

2.8

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

3652

14964

1.64

144.83

3.1

2.7

56.8

65.4

ml/min/173m2

33.01

1685

5684

(3013290) Carbon dioxide [Partial pressure] in Blood

1349

3990

2.23

143.96

5.1

3.8

5.0

kpa

0.33

1323

3894

(3012501) Base excess in Blood by calculation

1348

3989

2.23

143.69

5.1

3.7

2.5

2.6

mmol/l

1.36

935

2777

(1616796) Gas panel - Central venous blood

1325

3917

2.23

141.54

4.8

3.4

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2220

7956

1.85

140.49

4.9

3.6

49.4

48.2

1.54

2197

7871

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2906

11290

1.72

140.44

4.3

3.3

1.8

mmol/l

0.06

2116

8525

(3021901) Oxygen saturation in Capillary blood

1142

3201

2.34

137.82

3.2

2.7

—

(3013512) EKG study

11184

57809

1.36

137.14

5.7

3.6

—

(3033658) Prothrombin time (PT) actual/Normal

9699

49008

1.38

136.85

5.0

3.9

84.2

90.0

85.42

9456

47865

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

8087

39916

1.40

129.88

1.8

1.7

45017881.5

33457411.1

pmol/l

0.75

6593

32352

(3035350) Ketones [Presence] in Urine by Test strip

16227

89168

1.32

129.58

4.6

3.6

0.0

estimate

0.28

3278

15685

(3044640) Blood type and Crossmatch panel - Blood

11427

59665

1.35

129.25

3.0

2.4

—

(3037467) Urinalysis macro (dipstick) panel - Urine

22237

127857

1.33

128.93

5.3

4.3

—

(3026782) Osmolality of Urine

7562

36933

1.41

128.93

3.4

2.7

528.4

555.9

mosm/kgh2o

22.29

6470

31249

(3009261) Glucose [Presence] in Urine by Test strip

16367

90631

1.31

119.88

4.7

3.6

0.0

estimate

0.27

3107

15685

(3019150) Specific gravity of Urine by Refractometry

7740

38374

1.39

119.29

5.1

4.1

1.0

kg/l

0.52

1175

5772

(42870588) Differential panel, method unspecified - Blood

12125

64419

1.33

119.26

6.2

6.0

—

(3028271) Lactate [Moles/volume] in Capillary blood

986

2771

2.33

118.16

2.1

1.8

1.7

1.8

mmol/l

0.78

967

2705

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3367

14217

1.58

116.57

5.3

3.6

122.8

85.9

ng/l

47.36

2924

12089

(3021601) Nitrite [Presence] in Urine by Test strip

16169

89592

1.30

116.54

5.9

4.8

0.0

estimate

0.08

3322

16043

(3020630) Protein [Mass/volume] in Serum or Plasma

3780

16439

1.54

114.93

2.4

2.7

65.7

66.5

g/l

7.56

3500

14823

(3019230) Fractional oxyhemoglobin in Venous blood

1036

3018

2.25

114.34

3.6

2.7

67.9

63.4

7.63

1030

3008

(3015736) pH of Urine

12897

69448

1.31

113.67

4.3

3.4

5.7

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1464

4913

1.96

112.14

3.0

2.4

3.7

g/l

0.35

1416

4688

(40761535) Cells panel - Urine sediment

3580

15475

1.55

111.64

4.1

3.4

—

(3022096) Basophils/100 leukocytes in Blood

15106

83461

1.29

108.07

6.6

6.2

0.7

4.57

14181

77382

(3022806) Fractional oxyhemoglobin in Capillary blood

810

2174

2.44

107.26

2.0

1.8

89.3

89.5

0.58

797

2146

(3006504) Eosinophils/100 leukocytes in Blood

15476

85884

1.29

106.38

6.6

6.2

2.9

2.37

14513

79606

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

8924

45926

1.34

106.17

2.8

2.4

—

(3019069) Monocytes/100 leukocytes in Blood

15542

86371

1.29

105.25

6.9

6.5

9.0

8.8

12.12

14611

80371

(3011397) Hemoglobin [Presence] in Urine by Test strip

8415

43146

1.34

101.81

4.4

3.6

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4581

21208

1.45

101.81

2.6

2.8

8.6

9.6

umol/l

2.25

4020

18608

(21494755) Public health laboratory ask at order entry panel

1130

13754

0.51

101.78

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1492

5226

1.88

100.56

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

12481

67898

1.29

97.10

5.0

3.8

—

(3026250) Tacrolimus [Mass/volume] in Blood

373

684

3.54

95.74

38.4

33.9

7.4

7.2

ug/l

0.71

341

609

(3002030) Lymphocytes/100 leukocytes in Blood

15737

88326

1.27

94.33

6.7

6.3

25.5

27.5

88.45

14719

81683

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1248

4216

1.94

93.58

2.6

2.1

127.0

130.3

g/l

3.99

965

2920

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

3876

17669

1.47

92.61

1.5

—

(3018010) Neutrophils/100 leukocytes in Blood

15500

87002

1.27

91.93

6.5

6.0

59.1

57.4

53.05

14546

80854

(3021589) Normoblasts [#/volume] in Blood

14507

80855

1.27

90.85

12.8

9.7

0.0

e9/l

0.16

12081

65877

(3042733) HLA Ab [Presence] in Serum

317

541

3.80

89.89

5.3

4.8

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

30071

183886

1.39

89.76

22.9

14.1

25.7

25.4

mg/l

0.91

25884

145501

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

9577

50775

1.30

88.72

1.9

1.6

1.4

mmol/l

4.62

7879

42028

(3013707) Erythrocyte sedimentation rate by Westergren method

23349

137983

1.27

87.87

4.8

4.1

15.1

12.7

mm/h

80.87

21636

126533

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3431

15512

1.47

85.00

2.1

2.4

367.3

374.7

nmol/l

1.20

3152

14251

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1179

4064

1.90

83.22

1.6

1.7

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1214

4227

1.88

83.13

1.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

828

2515

2.15

82.50

7.5

6.0

11.9

11.6

mg/l

1.09

746

2316

(3004588) Protein electrophoresis panel - Serum or Plasma

3086

13775

1.49

81.28

2.2

2.5

—

(40768797) Stomach Pathology biopsy report

5301

26137

1.36

80.03

1.3

—

(4010399)

3075

13771

1.48

79.60

1.5

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

6574

33514

1.33

79.40

3.1

2.8

1.1

1.2

e6/l

0.45

3985

18881

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

769

2331

2.15

77.02

1.6

1.5

—

(40758558) Short blood count panel - Blood

8825

47118

1.28

74.59

6.6

7.3

—

(3036489) Thrombin time

1628

6441

1.66

72.03

2.7

1.9

22.6

21.4

5.00

1478

5672

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

22925

136416

1.24

71.95

4.3

3.9

15.1

14.9

pmol/l

12.77

20808

122128

(40760888) Immunoglobulin light chains.free panel - Serum

1267

4692

1.77

71.10

2.7

3.7

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1570

6185

1.67

70.59

2.8

3.5

7.6

3.3

ratio

0.43

110

432

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3331

15502

1.43

70.03

5.3

3.7

1.2

mmol/l

14.41

2930

13395

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1603

6376

1.65

69.45

2.9

3.6

44.0

44.2

mg/l

0.01

1260

5239

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1261

4701

1.76

69.16

3.3

2.4

214.0

196.4

8.96

1203

4438

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

557

1544

2.35

68.81

1.3

1.5

1.4

nmol/l

2.54

497

1395

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2579

11465

1.49

68.78

1.8

1.7

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1600

6389

1.64

68.25

2.9

3.6

97.0

64.3

mg/l

0.41

1256

5245

(40760892) CBC W Ordered Manual Differential panel - Blood

7144

37571

1.28

66.76

5.1

4.7

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

28797

176534

1.29

66.05

5.7

3.9

1.4

1.3

mmol/l

38.45

26689

158546

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1926

8132

1.56

65.17

1.4

1.6

14.2

16.4

u/ml

0.17

228

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1347

5202

1.70

65.15

2.9

2.1

88.1

90.8

4.05

1284

4835

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

4937

24807

1.33

64.28

10.9

6.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

901

3116

1.89

62.90

1.6

1.5

—

(3022313) Gas panel - Capillary blood

2015

8665

1.53

62.74

4.7

3.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1420

5620

1.66

62.62

1.9

1.7

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1403

14214

0.62

62.56

2.2

1.8

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

793

2666

1.94

60.19

1.5

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1236

4785

1.69

59.20

3.9

2.8

1.9

1.5

mg/l

37.59

1128

4345

(3040151) Glucose [Moles/volume] in Capillary blood

625

1945

2.09

58.60

8.5

9.3

7.8

7.4

mmol/l

1.85

519

1605

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

892

3151

1.85

58.33

1.6

1.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

721

2379

1.97

57.74

1.5

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

1081

4076

1.73

56.93

2.4

2.8

31.6

35.0

umol/l

4.55

911

3456

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3587

17488

1.36

56.48

2.8

2.5

38.4

47.6

u/l

1.50

3045

14988

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1639

6889

1.56

56.40

2.7

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

812

2816

1.88

56.21

1.3

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1155

4455

1.69

56.06

1.5

1.6

—

(3003434) Protein [Mass/volume] in Pleural fluid

758

2573

1.92

55.95

1.5

1.4

29.7

34.4

g/l

18.00

674

2333

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

5953

31210

1.28

55.56

3.3

3.0

2.3

2.4

e6/l

0.26

3410

16673

(3000492) Spirometry study

3412

16578

1.36

54.80

1.6

1.5

—

(44806118)

584

1839

2.07

53.13

1.6

1.5

—

(44790047)

584

1840

2.06

53.06

1.6

1.5

—

(44790049)

584

1840

2.06

53.06

1.6

1.5

—

(44790048)

584

1840

2.06

53.06

1.6

1.5

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

27309

167402

1.24

52.79

5.3

4.6

2.1

mu/l

0.08

25012

150799

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

607

1954

2.02

52.07

1.6

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

533

1635

2.12

51.90

2.2

2.5

0.1

0.5

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1496

6277

1.56

51.82

1.6

280.6

250.7

titre

0.16

249

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

983

3721

1.72

51.05

7.8

5.4

1907.4

2212.5

iu/ml

0.08

187

581

(3052851) Hemolysis interference index of Serum or Plasma

1377

5690

1.58

50.93

4.1

3.1

—

(3016750) Collection duration of Urine

378

1015

2.42

50.17

2.6

2.0

500.4

495.7

min

0.35

284

715

(40761536) Microorganisms panel - Urine sediment

3109

15128

1.36

49.18

5.3

4.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

840

9093

0.59

48.87

1.7

1.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

858

3165

1.77

48.74

5.5

2.8

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

11516

65524

1.20

48.43

3.4

3.6

2.3

2.4

mmol/l

8.25

10027

56319

(3017181) Myelocytes/100 leukocytes in Blood

3213

15751

1.35

48.37

4.0

4.1

0.9

1.0

0.76

976

4793

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

3715

18605

1.32

48.35

2.1

2.3

0.2

g/l

4.61

3405

17271

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

459

1369

2.18

47.96

1.5

—

(3004775) Volume in Urine collected for unspecified duration

474

1439

2.14

47.41

2.7

2.1

729.2

680.2

1.47

338

931

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

998

3875

1.68

47.25

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

998

3877

1.68

47.16

1.4

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

3298

16304

1.34

46.86

1.9

1.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

869

3262

1.74

46.49

1.8

1.4

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

686

2404

1.86

46.04

2.0

2.3

32.3

32.8

2.09

680

2387

(3022493) Free Hemoglobin [Mass/volume] in Plasma

280

678

2.68

45.79

13.0

3.6

1451.2

2554.3

mg/l

0.40

212

470

(3002179) Metamyelocytes/100 leukocytes in Blood

2926

14269

1.35

45.45

3.8

4.0

0.6

0.7

0.52

697

3471

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

790

2906

1.77

45.32

1.8

1.4

129.1

112.4

u/ml

1.48

201

628

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

771

2821

1.78

45.03

3.0

2.6

3347.4

6416.0

u/ml

0.36

176

(3023419) Bacteria identified in Sputum by Culture

669

2347

1.85

44.75

2.1

2.5

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

857

3243

1.72

44.57

1.7

1.4

16.7

16.0

u/ml

0.06

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

932

3610

1.68

44.53

1.2

81.4

147.6

titre

0.97

(3025159) Blasts/100 leukocytes in Blood

2855

13970

1.35

43.28

4.0

4.2

0.2

0.3

0.20

759

3747

(3037522) Nuclear Ab [Titer] in Serum

4461

23209

1.27

43.14

1.4

1.3

585.2

533.6

titre

0.89

987

4875

(3024932) HLA-DR beta [Type]

241

557

2.80

42.98

1.0

1.1

—

(3021440) Promyelocytes/100 leukocytes in Blood

3028

14970

1.33

42.81

4.0

4.2

0.1

1.15

893

4450

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

6641

36190

1.23

42.48

2.9

3.3

2.5

mmol/l

2.28

5712

31758

(3028026) IgM [Mass/volume] in Serum or Plasma

2204

10399

1.39

41.92

1.8

2.0

1.2

1.4

g/l

1.69

2022

9381

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

320

868

2.39

41.65

2.2

2.1

204.5

77.9

ug/min

0.92

188

(3010375) cycloSPORINE [Mass/volume] in Blood

296

774

2.48

41.63

27.3

29.4

110.0

115.7

ug/l

0.74

227

662

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

694

2520

1.79

41.60

1.6

1.5

—

(3023199) Leukocytes [#/volume] in Pleural fluid

655

2344

1.82

41.17

1.5

2196.1

3666.6

e6/l

1.18

480

1693

(3005719) IgG [Mass/volume] in Serum or Plasma

2732

13398

1.34

40.70

2.6

2.9

10.4

10.6

g/l

1.64

2539

12173

(3024471) HLA-A [Type]

241

576

2.71

40.46

1.0

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

734

2736

1.75

40.27

1.4

1.2

303.8

281.1

u/ml

1.01

492

1724

(3036782) Glucose [Moles/volume] in Pleural fluid

519

1744

1.93

39.57

1.4

1.3

7.1

6.1

mmol/l

10.81

480

1607

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

13251

77281

1.17

39.04

4.7

4.9

2.4

3.3

ug/l

6.06

11843

69841

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1200

5110

1.53

38.84

1.7

1.5

1.2

g/l

0.03

1141

4853

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1169

4952

1.54

38.74

1.7

1.5

0.2

g/l

1.57

1111

4677

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3355

17057

1.30

38.58

1.9

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2507

20983

0.75

37.80

1.3

1.4

—

(3019977) pH of Arterial blood

339

986

2.23

37.74

2.6

2.4

7.4

1.70

126

369

(3025941) Bacteria identified in Stool by Culture

1965

9255

1.39

37.67

1.3

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2082

9941

1.37

36.72

3.1

3.3

4.3

4.4

pmol/l

10.44

1834

8763

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1038

4334

1.56

36.68

1.6

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

583

6444

0.58

36.64

1.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

758

2962

1.66

35.09

1.3

1.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

508

1776

1.86

34.45

1.4

1.3

295.0

557.6

u/l

4.72

482

1679

(3012441) Differential panel - Pleural fluid

563

2038

1.79

34.17

1.5

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

859

3506

1.59

33.46

3.4

3.3

4.3

4.1

e9/l

1.75

859

3498

(3037756) Immunofixation for Serum or Plasma

1019

4338

1.53

33.04

1.5

1.7

—

(3020876) Protein [Mass/time] in 24 hour Urine

465

1607

1.88

32.71

2.0

1.9

0.8

g/24h

1.21

(3034770) Mitochondria Ab [Titer] in Serum

1103

4789

1.50

32.61

1.2

807.2

961.0

titre

0.44

148

(3017569) Oxygen content in Arterial blood

275

782

2.28

32.36

2.0

2.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

576

2138

1.75

32.15

1.5

57341.5

60566.1

e6/l

0.08

352

1262

(3011648) Oxygen content in Venous blood

415

1390

1.94

32.04

2.3

2.1

10.3

11.2

3.81

415

1390

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1635

7681

1.39

31.75

5.0

3.6

24.7

25.0

mmol/l

3.28

1509

7049

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

6322

35133

1.20

31.70

1.3

1.2

1.5

1.9

u/ml

1.18

1658

8721

(3045788) Cell count panel - Pleural fluid

498

1779

1.82

31.59

1.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

771

3110

1.61

31.55

1.2

1.3

31.7

36.6

u/l

0.65

677

2692

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

12915

76006

1.15

31.42

2.5

2.2

76.6

79.0

nmol/l

18.18

11412

67192

(3045716) Anion gap in Serum or Plasma

261

739

2.29

31.04

2.3

2.6

9.0

9.1

mmol/l

0.18

187

525

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1270

5770

1.43

29.81

1.5

1.4

257.5

263.9

ug/g

0.53

782

3384

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1090

4809

1.48

29.80

1.7

2.0

11.8

11.4

mg/l

0.38

1012

4447

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1654

7870

1.37

29.72

2.2

2.4

3.8

3.9

g/l

0.28

1211

5591

(21494890) Protein electrophoresis panel - 24 hour Urine

557

2096

1.72

29.68

1.9

2.2

—

(3011985) Renin [Units/volume] in Plasma

632

2463

1.67

29.62

1.3

1.4

98.2

55.4

mu/l

2.53

554

2177

(3000963) Hemoglobin [Mass/volume] in Blood

31165

205171

0.81

29.57

34.4

21.0

132.8

136.4

g/l

263.95

30817

201742

(3007566) Smooth muscle Ab [Titer] in Serum

1093

4833

1.47

29.55

1.2

111.1

133.9

titre

0.40

398

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1654

7890

1.37

29.25

2.2

2.4

—

(3010813) Leukocytes [#/volume] in Blood

31165

205148

0.81

29.24

34.2

20.9

7.2

6.7

e9/l

207.11

30427

198167

(3026361) Erythrocytes [#/volume] in Blood

31163

205128

0.81

29.12

34.2

20.9

4.4

4.5

e12/l

201.63

30420

198123

(3024731) MCV [Entitic volume]

31162

205121

0.81

29.11

34.0

20.8

91.7

91.4

23.67

30817

201659

(40757494) Bilirubin.total [Moles/volume] in Blood

311

972

2.07

29.10

1.9

2.2

28.7

27.0

umol/l

0.05

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1654

7899

1.37

29.04

2.2

2.4

7.7

7.4

g/l

7.80

1245

5877

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

119

228

3.37

29.02

6.4

4.7

41.3

51.5

ug/min

1.04

101

191

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

126

251

3.24

28.97

3.1

2.3

147.1

50.6

mg/l

—

(3035941) MCH [Entitic mass]

31160

205088

0.81

28.80

34.0

20.8

30.4

2.95

30817

201634

(3014765) Yersinia sp identified in Stool by Organism specific culture

1106

4927

1.46

28.80

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

1107

4935

1.46

28.72

1.2

—

(40768804) Tissue Pathology biopsy report

10992

77774

0.87

28.66

2.1

2.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

266

787

2.19

28.58

1.9

2.1

—

(3003181) Sodium [Moles/volume] in Urine

819

3439

1.55

28.29

1.4

1.3

59.4

62.2

mmol/l

1.26

661

2697

(3007164) IgA [Mass/volume] in Serum or Plasma

5627

31234

1.19

28.17

1.5

2.7

2.6

g/l

3.29

3346

18139

(3048929) Epstein Barr virus Ab [Presence] in Serum

901

3882

1.51

27.67

1.3

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1091

4889

1.45

27.56

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1547

7371

1.37

27.55

2.2

2.4

10.0

10.3

g/l

1.87

1315

6095

(3007461) Platelets [#/volume] in Blood

31161

205005

0.81

27.55

34.2

20.9

238.0

247.7

e9/l

120.53

30551

198742

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

903

3908

1.50

27.15

1.6

—

(3012565) Volume of 24 hour Urine

283

877

2.09

27.12

2.2

1793.0

1973.9

1.75

249

773

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1591

7682

1.35

26.03

1.7

2.0

37.8

39.5

u/l

2.17

1310

6750

(3035880) pH of Pleural fluid

317

1041

1.97

26.01

1.3

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

31032

195411

1.21

25.93

29.2

16.0

139.5

139.7

mmol/l

47.62

30601

190202

(3042631) Mycobacterium sp identified in Specimen

677

2778

1.58

25.88

2.5

2.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1548

7451

1.36

25.84

2.2

2.4

3.1

g/l

2.31

1226

5721

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

120

250

3.10

25.77

4.9

5.0

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

224

645

2.25

25.73

1.5

1.4

63.3

62.1

0.19

177

537

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

29236

183142

1.18

25.72

6.4

4.4

1.3

1.5

mmol/l

307.65

27254

165983

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

418

1513

1.79

25.51

2.2

2.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2051

10319

1.30

25.16

2.5

2.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

409

1479

1.79

25.05

1.1

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

475

1800

1.71

24.78

3.4

2.7

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

9.68

24.57

10.0

8.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

578

2313

1.62

24.52

1.2

1.3

244.2

281.4

pmol/l

1.41

425

1786

(46235355) HIV 1 and 2 tests - Meaningful Use set

3648

19686

1.22

24.35

1.9

1.6

—

(40768446) Kidney Pathology biopsy report

231

691

2.16

24.26

1.9

1.6

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

9.82

24.10

9.7

8.1

45.3

50.9

0.33

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

29240

183393

1.17

23.76

6.2

4.7

6.4

6.0

mmol/l

307.65

26813

165427

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1635

8049

1.32

23.46

2.0

1.9

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1240

5853

1.38

23.41

2.3

2.4

0.0

g/l

0.22

1148

5327

(40768806) Pleura Pathology biopsy report

525

2077

1.64

23.33

1.6

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

291

973

1.94

22.76

1.4

1.2

nmol/l

0.08

221

748

(3051651) Icteric interference index of Serum or Plasma

313

1073

1.89

22.74

4.7

3.7

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

851

3779

1.46

22.59

2.8

1.6

0.9

0.8

nmol/l

3.58

701

3155

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

187

528

2.29

22.55

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1342

6458

1.35

22.44

1.2

1.1

1.0

u/ml

0.15

136

559

(4034850)

1251

5963

1.37

22.24

15.1

9.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

694

2969

1.52

22.12

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

8051

46710

1.14

22.07

4.3

3.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

5267

29626

1.17

21.95

1.3

39.5

41.3

iu/ml

0.24

1620

9231

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1160

5476

1.38

21.89

2.3

2.4

0.0

g/l

0.76

1069

4962

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

191

552

2.24

21.84

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

31050

195958

1.19

21.79

29.4

16.1

4.0

mmol/l

249.48

30588

190436

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

297

1016

1.89

21.74

1.2

—

(3002385) Erythrocyte distribution width [Ratio]

24142

149698

1.13

21.68

27.5

17.4

14.0

13.7

142.40

23740

146374

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

618

2592

1.55

21.57

1.3

0.2

0.3

nmol/l

0.80

191

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1141

5390

1.38

21.45

2.3

2.4

0.0

g/l

0.00

1065

4946

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1501

7401

1.32

21.31

1.9

1.8

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

271

909

1.93

21.05

3.3

3.8

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

291

1000

1.88

21.03

1.7

1.9

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

29397

184806

1.16

20.83

6.4

4.4

3.9

4.8

mmol/l

307.65

27607

168503

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

4.73

20.81

4.0

3.0

—

(3000494) Fungus identified in Specimen by Culture

4087

22606

1.19

20.73

1.6

1.4

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

615

2602

1.53

20.66

1.3

2.4

1.4

nmol/l

0.24

584

2502

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1126

5347

1.37

20.51

1.6

1.4

10.9

15.4

iu/ml

1.00

122

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

10437

61814

1.13

20.37

4.3

4.2

23.0

21.5

17.01

4894

30037

(3051611) Lipemic interference index of Serum or Plasma

500

2029

1.60

20.14

4.4

3.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

542

2255

1.56

19.65

1.3

—

nmol/l

—

(3008037) Lactate [Moles/volume] in Venous blood

877

4029

1.41

19.45

4.3

2.8

1.6

mmol/l

0.70

852

3946

(43055442) Apixaban [Mass/volume] in Serum or Plasma

103

234

2.84

19.25

1.5

1.4

126.4

110.0

ug/l

0.68

179

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1263

6165

1.33

19.24

2.2

2.3

36.8

37.7

g/l

5.12

1116

5220

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

4903

27708

1.16

18.99

1.3

1.2

12.0

14.5

u/ml

1.42

1739

9980

(3049717) Cytology report of Urine Cyto stain

1621

8205

1.29

18.96

2.7

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

316

1155

1.77

18.83

1.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

377

1453

1.68

18.63

1.3

11.9

14.2

u/l

1.02

344

1347

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

561

2383

1.53

18.56

1.3

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

254

871

1.89

18.55

1.9

2.2

96.0

98.3

0.40

244

823

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

286

1023

1.81

18.32

1.6

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

287

1029

1.80

18.24

1.6

1.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1357

6744

1.31

18.23

2.4

2.6

0.8

1.0

g/l

1.60

1199

5702

(3000093) Morphology [Interpretation] in Blood Narrative

452

1836

1.59

18.19

1.2

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

263

924

1.84

17.85

12.9

9.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

562

2409

1.51

17.85

1.5

1.3

—

(3025315) Body weight

144

3.32

17.82

6.0

4.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

308

1139

1.75

17.67

1.2

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

406

1621

1.62

17.55

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

216

715

1.95

17.53

3.2

2.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

293

3183

0.59

17.40

3.1

3.6

29.6

42.6

u/ml

1.85

278

3086

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

5.38

17.31

6.3

4.9

415.9

416.1

umol/l

0.00

(3014891) Appearance of Pleural fluid

223

2.78

17.30

1.8

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1228

10215

0.77

17.26

1.2

1.3

—

(3000034) Microalbumin [Mass/volume] in Urine

442

1810

1.58

17.22

3.4

3.0

85.7

44.5

mg/l

1.42

327

1304

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

357

1399

1.65

16.63

1.5

1.4

14.2

12.3

u/l

5.47

342

1345

(3022621) pH of Urine by Test strip

2279

12176

1.22

16.60

3.4

2.9

—

(40768793) Breast Pathology biopsy report

406

4042

0.64

16.59

1.3

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

189

614

1.99

16.21

2.2

175.6

160.2

1.35

175

573

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

458

4417

0.66

16.05

1.3

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

104

264

2.54

15.89

1.4

11.0

11.3

0.04

141

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1938

10234

1.23

15.79

3.4

2.7

0.3

e6/l

0.57

1914

9981

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

316

1218

1.68

15.71

1.2

12.2

mmol/l

0.02

124

404

(3033923) Metanephrine [Moles/time] in 24 hour Urine

130

371

2.26

15.48

1.1

0.7

umol/24h

0.01

183

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

167

529

2.04

15.37

3.0

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

167

529

2.04

15.37

3.0

2.3

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

174

561

2.00

15.27

1.5

1.4

2.7

2.5

0.17

145

480

(3024891) Influenza virus A+B Ag [Presence] in Specimen

852

4077

1.36

14.89

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

238

860

1.79

14.86

1.1

—

(3035285) Chloride [Moles/volume] in Venous blood

509

2227

1.48

14.74

3.0

2.1

105.5

mmol/l

0.06

503

2213

(3041354) Potassium [Moles/volume] in Venous blood

509

2227

1.48

14.74

3.0

2.1

4.1

mmol/l

2.59

503

2213

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

4.15

14.72

12.6

8.9

156.8

369.0

e6/l

0.73

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

400

1663

1.56

14.69

1.4

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

400

1663

1.56

14.69

1.4

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

400

1663

1.56

14.69

1.4

1.7

—

(3045414) Leukocytes [Presence] in Urine

1607

8387

1.25

14.59

2.2

1.8

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

421

1774

1.54

14.57

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

106

1485

0.46

14.57

1.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

222

791

1.81

14.52

2.5

3.0

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

548

2446

1.45

14.35

1.1

1.6

1.5

g/l

3.51

499

2201

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

462

1993

1.50

14.35

1.5

1.8

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

144

443

2.10

14.34

1.4

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

855

4119

1.35

14.32

1.3

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

1825

9679

1.23

14.28

1.3

227.2

266.0

u/ml

0.86

1667

8930

(3038515) Glucose [Moles/volume] in Venous blood

807

3855

1.36

14.28

4.5

2.9

8.0

7.6

mmol/l

3.72

787

3784

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

29907

189112

1.14

14.25

7.3

4.9

2.1

2.8

mmol/l

307.65

28007

171567

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

479

2085

1.49

14.24

1.2

56.1

63.4

u/l

1.61

331

1373

(3017704) Immunofixation for Urine

280

1076

1.68

14.13

1.4

1.7

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

343

0.11

14.05

1.7

1.5

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

4.54

13.83

12.7

12.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

120

349

2.22

13.73

1.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

548

4964

0.71

13.71

1.7

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

497

2201

1.46

13.58

3.1

2.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1054

8664

0.78

13.52

3.4

4.0

67.0

66.6

u/ml

0.01

1008

8337

(3047352) Trisomy 18 risk [Likelihood] in Fetus

331

0.12

13.39

1.5

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

432

1868

1.50

13.31

1.5

1.8

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

117

342

2.21

13.25

3.0

2.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

155

506

1.98

13.22

1.5

1.3

20.9

21.3

0.06

138

461

(3005033) Fetal Nuchal fold Thickness US

329

0.12

13.21

1.5

1.4

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

211

2.57

13.19

1.2

1.3

7.5

305658.8

nmol/l

1.54

177

(3004716) Salmonella sp identified in Stool by Organism specific culture

1349

6990

1.25

13.08

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

317

1286

1.59

12.99

1.3

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

854

4180

1.33

12.90

2.5

2.1

—

(3016038) Potassium [Moles/volume] in Urine

306

1240

1.60

12.62

1.2

1.1

34.4

34.3

mmol/l

0.04

266

1046

(40768800) Prostate Pathology biopsy report

593

5228

0.73

12.60

1.2

—

(3000012) Reticulocyte production index

271

1066

1.64

12.59

1.5

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

290

1164

1.61

12.44

1.5

1.4

15.2

13.0

umol/l

4.49

271

1105

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

645

3047

1.37

12.31

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

193

696

1.79

12.23

1.6

29.5

7.8

nmol/l

0.38

165

587

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

116

351

2.13

12.13

1.4

1.3

—

(40762365) Oxygen content in Arterial blood by calculation

107

315

2.19

11.97

2.6

3.4

15.3

14.7

ml/dl

1.49

299

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

997

0.41

11.96

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

527

2421

1.41

11.89

1.3

1.2

4.7

3.6

u/ml

0.99

263

1063

(3037121) Protein [Mass/volume] in Urine

1284

6702

1.24

11.70

3.1

3.2

0.4

0.3

g/l

3.22

589

2956

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

306

1266

1.56

11.60

1.4

—

(3011544) Albumin [Mass/volume] in Pleural fluid

168

2.65

11.56

1.1

14.9

18.1

g/l

2.78

148

(40757373) Influenza virus identified in Isolate

111

337

2.13

11.53

1.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3604

26103

0.88

11.46

6.0

4.6

33.9

31.9

21.55

2768

16755

(3052592) Norovirus Ag [Presence] in Stool

109

330

2.13

11.41

1.4

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

140

2.81

11.39

2.4

2.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

690

3339

1.34

11.32

1.5

1.6

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

123

392

2.03

11.29

5.9

6.4

68.8

71.1

0.37

308

(4035726)

2545

18863

0.86

11.26

1.5

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

537

2501

1.39

11.22

1.3

1.2

4.0

u/ml

0.02

183

866

(40758047) Lysozyme [Mass/volume] in Pleural fluid

156

2.69

11.20

1.2

1.1

8.8

9.1

mg/l

0.08

143

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

874

4383

1.29

11.12

1.5

1.3

—

(4146454)

510

2366

1.40

10.92

3.0

2.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

600

2861

1.36

10.87

1.5

1.6

0.8

g/l

0.07

440

2139

(3035320) C reactive protein [Mass/volume] in Body fluid

305

1281

1.54

10.86

2.9

2.4

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

247

991

1.61

10.70

1.2

224.0

352.0

u/l

1.45

224

921

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1957

10743

1.18

10.68

1.5

1.4

—

(4062490)

399

1779

1.45

10.65

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

678

5708

0.76

10.55

1.9

1.6

5.6

3.4

mg/l

2.46

524

4100

(3044927) Protein electrophoresis panel - Urine

456

2092

1.41

10.44

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

575

2742

1.36

10.43

1.1

33.3

4727.6

iu/ml

0.60

111

545

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

230

914

1.63

10.37

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

189

713

1.71

10.36

1.5

1.8

89.4

113.2

umol/l

0.87

363

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

6.16

10.35

3.5

—

(3020491) Glucose [Moles/volume] in Blood

305

1296

1.52

10.33

2.1

1.8

7.6

7.1

mmol/l

1.95

217

882

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

422

0.17

10.33

1.5

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1256

6638

1.23

10.24

1.1

13.2

8.9

u/ml

0.13

(4306422)

515

2422

1.38

10.20

1.3

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

110

351

2.02

10.11

1.3

1.2

1.3

1.8

mmol/l

5.14

206

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1047

5436

1.25

10.06

1.4

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

170

2.51

9.97

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

395

1785

1.43

9.86

1.4

7.0

6.8

g/l

0.18

274

1216

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

396

0.16

9.84

1.6

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

395

0.16

9.81

1.6

1.4

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

19140

119253

1.08

9.80

3.6

3.1

64.0

53.3

u/l

26.86

17665

109815

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

394

0.16

9.78

1.6

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

394

0.16

9.78

1.6

1.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

394

1783

1.43

9.77

1.4

0.4

g/l

1.34

277

1219

(3028192) IgG subclass 2 [Mass/volume] in Serum

394

1785

1.43

9.71

1.4

2.8

3.0

g/l

0.97

277

1215

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

336

1478

1.47

9.67

1.9

1.7

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1285

6850

1.22

9.65

1.1

204.2

225.1

titre

0.10

184

(4268621)

364

1628

1.45

9.62

2.4

2.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1003

5217

1.25

9.51

1.9

1.7

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

227

921

1.59

9.46

1.2

1.1

5.0

3.5

iu/ml

0.34

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

424

1956

1.40

9.46

3.6

3.8

—

(3050129) First trimester maternal screen panel - Serum or Plasma

472

0.25

9.45

1.7

1.4

—

(3000330) Specific gravity of Urine by Test strip

1732

9516

1.18

9.38

4.0

3.4

—

(3048689) Calprotectin [Mass/mass] in Stool

3393

19592

1.13

9.24

2.1

2.2

166.3

148.1

ug/g

1.64

2711

15232

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

165

1754

0.60

9.24

1.3

71.5

96.2

pmol/l

0.70

588

(3006442) Creatine [Moles/volume] in Serum or Plasma

284

1222

1.50

9.14

1.8

1.5

78.6

72.4

umol/l

0.70

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

182

2.38

9.11

1.2

1.1

16.3

20.4

u/l

1.35

125

(1761868) Lipid panel - Serum or Plasma

9150

62536

0.92

9.05

4.0

2.9

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

988

5172

1.24

8.87

1.6

11.9

7.8

iu/ml

0.20

226

1116

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

328

3000

0.70

8.86

1.5

1.8

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

136

489

1.80

8.86

1.4

25.9

22.7

0.58

109

415

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

161

2.45

8.82

1.2

92.7

124.6

ug/l

1.04

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

235

2.17

8.75

1.3

41.3

376.1

u/l

1.00

165

(3016650) Hepatitis A virus Ab [Presence] in Serum

555

2708

1.33

8.73

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

459

2185

1.36

8.52

2.2

2.3

7.2

6.3

titre

0.05

(3022689) Creatine [Moles/volume] in Urine

147

552

1.72

8.30

1.5

—

(3003129) Base excess in Capillary blood by calculation

139

516

1.74

8.18

1.7

1.8

0.7

mmol/l

0.01

127

490

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

4.58

8.16

3.6

3.9

—

(3002256) Pathology report gross observation

3635

25813

0.90

8.15

1.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

488

2362

1.34

8.15

1.2

1.1

111.5

118.8

4.24

445

2117

(3028300) Cannabinoids [Presence] in Urine

357

3172

0.72

8.14

2.4

1.9

—

(3027008) Opiates [Presence] in Urine

356

3162

0.72

8.10

2.3

1.8

—

(3027944) Amphetamines [Presence] in Urine

346

3087

0.72

8.10

2.5

1.8

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

147

559

1.70

7.96

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

355

3143

0.73

7.93

2.4

1.9

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1171

6313

1.20

7.90

1.6

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

117

420

1.80

7.73

1.3

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

233

1000

1.51

7.68

1.2

1.1

37.5

24.1

u/l

1.54

181

769

(44786800) Granulocytes/100 leukocytes in Body fluid

240

2.07

7.65

1.3

1.4

21.2

27.3

0.86

195

(3035637) Corticotropin [Mass/volume] in Plasma

466

2264

1.33

7.62

1.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

167

665

1.62

7.61

1.9

1.8

17161.1

9980.4

e6/l

0.56

356

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

314

1437

1.41

7.45

1.1

1.2

177.2

163.3

titre

0.11

236

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

105

369

1.84

7.44

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

232

1002

1.50

7.43

1.1

110.2

83.2

u/l

2.21

187

798

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

382

1809

1.37

7.40

1.3

1.1

92.7

97.6

2.75

368

1671

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

204

859

1.53

7.36

2.5

2.3

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

313

1435

1.41

7.36

1.1

1.2

110.0

167.3

titre

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

545

2721

1.30

7.35

1.8

1.9

26.7

24.7

ug/l

0.23

526

2667

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

496

2448

1.31

7.28

1.2

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

138

530

1.68

7.25

1.4

1.7

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

263

2408

0.70

7.25

1.5

1.8

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

109

391

1.80

7.25

2.7

2.4

8.1

7.5

mmol/l

0.59

245

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

117

429

1.76

7.24

1.1

77.8

87.6

2.14

205

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

290

1.94

7.23

1.4

1.2

93.0

411.6

ng/l

0.61

197

(3047189) Immunofixation for 24 hour Urine

223

962

1.50

7.20

1.7

1.8

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

413

3521

0.75

7.20

1.4

154.5

182.7

pmol/l

0.92

401

3437

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

164

660

1.60

7.20

1.9

1.7

75517.2

16064.8

u/ml

0.58

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

166

673

1.59

7.08

1.2

1.1

5.5

15.6

u/ml

0.72

(3013139) Helicobacter pylori Ag [Presence] in Stool

2079

11839

1.14

7.06

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

319

1480

1.39

7.02

1.5

1.3

1.4

promille

0.82

234

1163

(3044416) Complement C4 [Mass/volume] in Pleural fluid

2.89

7.02

1.1

1.3

0.1

g/l

0.56

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

537

2694

1.29

7.00

1.2

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

171

701

1.58

6.97

1.7

1.5

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

182

757

1.55

6.97

2.1

1.9

3631.7

1642.6

e6/l

0.34

129

511

(3016879) Cocaine [Presence] in Urine

341

2971

0.74

6.93

2.3

1.9

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

559

2823

1.28

6.93

1.0

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

132

508

1.68

6.91

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

124

472

1.70

6.77

1.1

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

226

2.03

6.73

1.4

73.8

71.2

0.29

187

(3042010) Triglyceride [Moles/volume] in Pleural fluid

289

1.90

6.70

1.3

1.2

0.7

1.7

mmol/l

1.52

187

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

116

435

1.72

6.68

1.2

99.0

105.8

0.90

104

401

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

259

1170

1.43

6.66

1.2

30.5

25.0

u/l

0.77

220

987

(3022145) Colonoscopy Study observation

3740

22106

1.10

6.62

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

457

2263

1.31

6.60

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

140

2.30

6.48

1.5

2.5

0.9

1.0

mmol/l

0.23

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

703

3678

1.24

6.47

1.3

1.2

8.3

12.1

u/ml

0.25

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

199

2.08

6.47

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

264

1206

1.41

6.40

1.2

100.2

89.6

u/l

0.80

229

1039

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

331

1.81

6.40

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

141

564

1.61

6.40

1.5

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

123

475

1.67

6.39

1.7

1.9

—

(3004809) Band form neutrophils/100 leukocytes in Blood

650

3378

1.25

6.37

3.3

3.5

1.3

1.5

0.84

504

2602

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

112

422

1.71

6.37

1.2

75.2

88.0

2.11

205

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

290

1.87

6.36

1.3

1.2

89.4

85.0

0.37

(3003694) ABO and Rh group [Type] in Blood

7919

48358

1.07

6.34

1.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

423

2085

1.31

6.34

1.3

1.2

69.0

56.6

u/ml

0.46

132

(3010144) Erythrocytes [#/volume] in Synovial fluid

394

1926

1.32

6.27

1.3

1.4

151782.0

110463.7

e6/l

0.46

266

1322

(3012898) Urea [Moles/volume] in Urine

176

2.13

6.25

1.5

1.3

139.3

173.8

mmol/l

1.61

153

(3044007) Cell count panel - Peritoneal fluid

146

595

1.58

6.16

2.1

1.9

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

317

1.81

6.13

1.1

6.7

8.5

pmol/l

0.10

(3013637) Mi-2 Ab [Presence] in Serum

111

423

1.69

6.08

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

111

423

1.69

6.08

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

111

423

1.69

6.08

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

111

423

1.69

6.08

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

261

1207

1.40

5.94

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

400

1977

1.31

5.91

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

226

1022

1.43

5.84

1.9

1.8

2.2

2.3

u/field

0.14

167

724

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

229

1039

1.42

5.81

1.6

1.4

7.7

5.6

u/l

1.27

197

870

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

183

2.04

5.69

1.1

1.9

1.7

umol/24h

0.73

183

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

344

1.74

5.69

1.2

55.8

32.6

mg/l

0.16

258

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

292

1.81

5.68

1.3

1.2

78.7

77.3

0.10

(3000475) Leukocytes [#/volume] in Synovial fluid

917

4994

1.19

5.66

1.6

15394.2

14208.9

e6/l

0.28

657

3591

(3034426) Prothrombin time (PT)

133

543

1.58

5.61

1.4

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

163

2.10

5.56

1.5

1.6

50.8

43.0

umol/l

0.79

163

(3033799) Differential panel - Peritoneal fluid

155

661

1.51

5.41

2.0

1.9

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

158

677

1.51

5.40

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

564

2947

1.24

5.34

1.4

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.71

5.26

1.2

8048.7

2127.5

ng/l

1.12

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

686

3666

1.21

5.23

1.3

1.2

5.6

6.2

u/ml

0.06

265

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

238

1110

1.38

5.22

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

806

4377

1.19

5.18

1.3

6.6

6.7

u/ml

0.02

128

708

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

238

1112

1.38

5.16

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

144

612

1.52

5.14

1.1

1714.2

1535.2

miu/ml

1.06

144

612

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

571

3003

1.23

5.11

1.3

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

969

5353

1.17

5.09

1.6

1.7

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

282

1361

1.34

5.00

1.0

1.1

293.8

285.9

mg/l

0.94

250

1209

(1001926) Buprenorphine [Presence] in Urine by Screen method

286

2428

0.76

4.99

2.6

1.9

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

117

479

1.58

4.94

1.5

1.3

29.2

40.4

g/l

0.41

361

(3025130) Human papilloma virus identified in Specimen

162

1493

0.70

4.81

1.6

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

261

1255

1.34

4.77

1.5

8.9

6.1

u/l

1.09

125

598

(3026692) Albumin [Mass/volume] in Peritoneal fluid

127

535

1.53

4.75

1.4

1.3

17.0

12.2

g/l

7.48

100

408

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

857

4719

1.18

4.72

1.3

1.2

37.6

39.4

u/ml

0.07

263

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

791

4330

1.18

4.68

1.3

5.5

5.8

u/ml

0.04

447

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

304

1500

1.31

4.66

1.5

24.7

25.4

u/ml

0.08

316

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1750

12527

0.90

4.59

2.4

26.9

28.0

au/ml

0.09

594

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

260

1.76

4.58

2.5

2.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

211

988

1.38

4.58

1.4

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

211

988

1.38

4.58

1.4

1.5

—

(3008295) Osmolality of Serum or Plasma

371

1884

1.27

4.57

1.4

1.3

279.8

277.3

mosm/kgh2o

1.07

301

1440

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

402

3232

0.80

4.55

1.4

1.5

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

3.32

4.54

1.1

1.3

—

(40761511) CBC panel - Blood by Automated count

29960

191223

1.07

4.48

22.7

13.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

600

0.55

4.45

2.9

2.5

118.0

152.3

nmol/l

1.58

514

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.28

4.44

1.2

1.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

145

640

1.46

4.38

1.4

1.3

3.4

3.6

mmol/l

0.32

127

592

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

5.37

4.37

1.1

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

847

0.62

4.33

12.4

12.7

0.7

0.6

mmol/l

0.38

775

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

611

3298

1.20

4.28

1.3

1.2

44.9

47.9

u/ml

0.18

317

(36660697) Celiac disease serology panel - Serum

2206

12994

1.10

4.25

1.2

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

141

2.01

4.24

1.4

1.2

14.9

17.2

pmol/l

0.19

121

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

126

545

1.49

4.22

1.3

1.4

15.5

15.6

pmol/l

0.03

106

456

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1056

7745

0.88

4.18

1.5

1.7

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

172

792

1.40

4.16

1.1

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

117

500

1.51

4.16

1.2

—

(3044941) Cell count panel - Synovial fluid

591

3191

1.20

4.14

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

268

1326

1.31

4.09

1.7

2.0

1761.8

2147.2

u/l

0.14

468

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

261

1287

1.31

4.08

1.3

413.1

511.6

titre

0.12

105

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

4.96

4.05

1.1

1.6

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

130

572

1.47

4.03

1.3

122.4

320.1

ug/l

1.18

324

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

318

1614

1.27

4.00

1.8

1.9

4.5

3.8

mg/l

1.62

300

1546

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

363

1874

1.25

3.96

1.5

24.1

30.8

3.42

234

1147

(3013166) Neutrophils/100 leukocytes in Synovial fluid

134

596

1.45

3.94

1.3

1.4

66.6

54.8

3.36

110

509

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1595

11370

0.90

3.92

1.3

59.9

52.5

au/ml

0.39

505

(3023323) Follitropin [Units/volume] in Serum or Plasma

442

3457

0.82

3.91

1.4

1.3

27.9

35.1

iu/l

4.26

373

2920

(3019832) Treponema pallidum Ab [Presence] in Serum

1088

6191

1.14

3.90

1.7

1.5

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

155

1.91

3.89

1.1

21.0

14.4

iu/ml

0.25

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

188

890

1.36

3.88

1.1

ratio

0.08

321

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

304

1545

1.27

3.80

2.1

1.8

2.5

u/field

1.10

141

618

(3006462) Nitrate [Presence] in Urine

189

901

1.35

3.75

3.2

3.4

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

3.13

3.73

1.0

1.2

—

(3006270) Folate [Moles/volume] in Blood

300

1530

1.27

3.66

1.2

356.0

349.6

nmol/l

0.17

237

1283

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

197

954

1.33

3.55

1.3

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

197

955

1.33

3.53

1.3

1.5

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

213

1046

1.31

3.49

1.1

8.5

5.6

nmol/l

0.40

221

(21494434) Karyotype in Bone marrow

345

1800

1.24

3.48

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

721

0.64

3.41

1.1

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

496

2689

1.19

3.41

1.6

1.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

136

1208

0.72

3.38

1.0

1.5

0.4

u/ml

0.46

287

(4211845)

200

980

1.32

3.35

3.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

483

2617

1.19

3.35

2.2

2.0

25.5

28.1

mg/l

0.43

121

683

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

470

2549

1.19

3.24

1.5

1.6

62.1

58.1

1.33

302

1616

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

162

1.79

3.18

1.2

1.3

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

2.48

3.17

1.3

1.4

99.3

107.3

ug/l

0.09

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

120

1074

0.72

3.15

1.3

1.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

197

973

1.31

3.15

3.9

3.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

743

0.67

3.09

1.3

1.6

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

5.73

3.08

1.1

1.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

313

1.55

3.07

1.1

1.3

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

127

1.88

3.04

1.2

1.1

12.1

11.2

u/l

0.12

127

(3019897) Erythrocyte distribution width [Ratio] by Automated count

199

1647

0.78

3.04

4.8

2.9

13.5

13.3

2.05

193

1620

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

130

0.30

3.03

5.8

7.3

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

247

1264

1.26

3.01

1.3

118.9

60.0

titre

0.39

101

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

213

1071

1.28

3.00

1.3

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

240

1225

1.26

2.99

1.8

2.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

330

1746

1.22

2.98

1.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

139

658

1.36

2.98

1.1

94.3

100.0

1.53

103

526

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

183

1526

0.77

2.97

4.2

5.3

24.3

123.5

u/ml

6.08

451

(3011288) Drugs identified in Urine by Screen method

246

1978

0.80

2.95

2.5

2.8

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

968

6966

0.89

2.93

1.4

1.6

—

(3046861) Legionella sp Ag [Presence] in Urine

1.99

2.92

1.2

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

255

1317

1.25

2.89

1.2

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

160

778

1.33

2.89

1.3

1.2

6.1

mmol/l

0.10

143

740

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

461

2527

1.18

2.86

1.4

—

(4281824)

270

2141

0.81

2.86

1.2

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

210

1062

1.28

2.85

1.3

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

210

1711

0.79

2.84

1.0

1.1

2.5

1.5

u/ml

0.58

393

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

108

495

1.41

2.82

1.3

34.9

38.0

0.32

327

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

2.22

2.78

1.3

1.1

170.8

179.6

ug/g

0.09

(3024522) Salmonella sp identified in Specimen by Organism specific culture

461

2536

1.17

2.75

1.4

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

132

1.81

2.74

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

161

1.72

2.72

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

266

1.55

2.71

1.0

1.1

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

4.15

2.71

1.1

1.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

455

2505

1.17

2.70

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

455

2507

1.17

2.68

1.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

826

0.71

2.67

1.5

1.3

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

128

610

1.35

2.67

1.9

2.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3363

20530

1.06

2.66

1.8

1.6

1.5

8.81

2841

17777

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

252

1.56

2.66

1.0

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

180

1478

0.78

2.63

1.0

4.7

3.1

u/ml

0.54

567

(3005988) Vibrio sp identified in Specimen by Organism specific culture

455

2512

1.17

2.62

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

260

2048

0.82

2.61

1.2

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

439

1.41

2.57

1.7

1.8

—

(3003740) Influenza virus B Ag [Presence] in Specimen

259

2037

0.82

2.57

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

135

1.77

2.57

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

259

2035

0.82

2.55

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

177

0.40

2.49

1.0

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

113

535

1.36

2.48

1.8

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

25355

165139

0.96

2.48

24.8

15.4

38.9

39.9

41.30

15748

114060

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

143

702

1.31

2.47

1.9

2.1

23.1

353.0

ug/l

1.44

135

665

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

467

2600

1.16

2.44

1.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

207

1070

1.25

2.40

1.4

1.3

1.4

1.5

g/l

0.54

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

143

1.71

2.40

1.4

1.5

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.91

2.40

1.1

1.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

3306

22427

0.95

2.39

1.4

1.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

424

0.62

2.36

2.0

1.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

699

4011

1.13

2.35

1.6

1.7

19.3

15.1

iu/l

0.10

204

1312

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

124

0.36

2.35

6.3

5.8

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

125

0.36

2.35

3.1

2.9

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

153

765

1.29

2.34

1.4

1.5

16.1

13.8

umol/l

0.16

555

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

175

891

1.27

2.32

1.3

1.1

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.03

2.29

1.3

1.1

233.1

504.6

u/l

0.86

(40759836) Histone Ab [Presence] in Serum by Immunoblot

234

1235

1.22

2.27

1.2

—

(40768795) Lymph node Pathology biopsy report

272

2099

0.83

2.26

1.1

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

136

1.71

2.26

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

235

1242

1.22

2.25

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

234

1237

1.22

2.24

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

235

1243

1.22

2.23

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

235

1243

1.22

2.23

1.2

—

(3018133) Calcium [Moles/volume] in Urine

222

1.54

2.23

1.4

1.6

2.2

2.6

mmol/l

0.78

196

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.88

2.23

1.8

1.4

25.4

23.4

mmol/l

0.92

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

103

1.82

2.23

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

234

1238

1.22

2.22

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

147

1.67

2.20

1.1

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

133

1.70

2.16

4.2

5.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

256

1973

0.84

2.12

1.0

1.1

2.9

3.1

u/ml

0.11

111

934

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

490

0.67

2.12

2.0

1.8

8.3

9.0

mg/l

0.46

389

(44813793)

204

1071

1.23

2.10

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

110

1.76

2.10

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

174

1391

0.81

2.10

1.1

1.0

2.3

3.0

u/ml

0.46

535

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

108

524

1.33

2.09

1.2

0.3

g/l

0.64

426

(3010370) Gastrin [Moles/volume] in Serum or Plasma

284

1.45

2.08

1.5

1.7

75.8

52.4

pmol/l

0.54

237

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

394

0.64

2.07

1.8

1.6

31.8

83.4

au/ml

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

175

1.58

2.07

2.5

2.1

64.8

58.4

0.53

106

(3015076) Soybean IgE Ab [Units/volume] in Serum

570

0.70

2.05

1.1

1.0

0.4

1.3

u/ml

0.49

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

448

1.35

2.05

2.1

2.5

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.96

2.03

1.1

1.0

106.3

176.9

pmol/l

—

(3008898) HLA-B27 [Presence]

623

4485

0.89

2.02

1.0

—

(3047185) IgG [Mass/volume] in Urine

2.25

2.01

1.0

1.1

—

42.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

530

0.69

2.01

1.1

1.3

—

(3024263) Appearance of Synovial fluid

203

1072

1.22

2.00

1.6

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

1.98

2.00

1.0

1.1

1.4

u/field

0.28

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

168

0.46

1.97

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

150

1205

0.80

1.92

1.5

1.4

0.2

nmol/l

0.17

837

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3357

22618

0.95

1.91

3.3

4.3

28.2

26.1

ug/l

0.11

2737

18654

(3015183) Erythrocyte sedimentation rate

711

0.74

1.91

1.3

1.2

—

(3028433) Virus identified in Specimen by Culture

129

651

1.28

1.90

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

370

0.64

1.90

3.0

2.0

2.8

6.8

ug/l

0.95

198

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

133

1080

0.79

1.88

4.3

5.7

1659.5

3825.0

u/ml

0.27

207

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

101

494

1.32

1.88

1.2

114.9

112.9

0.32

439

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

139

1.62

1.88

2.1

16.4

17.6

0.08

(3000285) Sodium [Moles/volume] in Blood

248

1.46

1.87

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

331

1842

1.16

1.84

1.7

1.4

28.0

23.7

iu/ml

0.47

(3045424) Erythrocytes [Presence] in Urine

577

3332

1.12

1.83

1.7

1.4

—

(3021788) Differential panel - Synovial fluid

656

3818

1.11

1.81

1.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

250

1895

0.85

1.77

1.1

u/ml

0.00

757

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

113

567

1.29

1.77

1.8

2.1

42.3

42.7

u/l

0.01

104

515

(3020618) Glucose [Moles/volume] in Synovial fluid

1.91

1.75

1.1

6.9

5.2

mmol/l

0.92

(3013293) Extractable nuclear Ab [Presence] in Serum

252

1.43

1.74

1.6

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

283

0.61

1.73

1.5

1.6

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

247

1.44

1.73

3.5

3.3

43.0

41.3

umol/l

0.23

214

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

143

1139

0.81

1.73

5.1

6.6

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

296

2208

0.86

1.72

1.1

2.9

1.3

u/ml

0.87

120

866

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

103

513

1.30

1.71

1.8

1.6

9.6

9.3

ug/l

0.25

103

513

(3023410) Appearance of Cerebral spinal fluid

242

1827

0.85

1.65

1.4

1.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

139

0.46

1.65

1.0

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

337

1896

1.15

1.65

1.1

1.6

2.0

iu/ml

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

367

2077

1.14

1.65

1.2

7.7

7.5

mmol/l

0.44

272

1507

(3019225) pH of Specimen

3132

21050

0.96

1.64

5.6

4.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

113

574

1.27

1.63

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

386

0.68

1.61

1.4

1.8

—

(3044290) Cell count panel - Cerebral spinal fluid

531

3796

0.90

1.59

1.2

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

341

1.34

1.55

1.6

1.5

—

(40765089) Chromosome analysis panel - Blood by G-banded

152

0.51

1.54

1.0

—

(21491868) Cryoglobulin [Mass/volume] in Serum

123

637

1.25

1.53

1.2

0.1

0.7

g/l

2.43

(3024869) Neuronal Ab [Presence] in Serum

398

1.31

1.52

1.1

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

112

1.61

1.51

1.1

u/field

0.09

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

277

1.37

1.49

1.4

1.2

—

(3019174) dRVVT (LA screen)

133

1.55

1.48

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

645

0.77

1.48

1.1

1.0

2.9

0.5

u/ml

0.58

151

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.74

1.47

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

108

868

0.80

1.47

1.7

1.5

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

2.65

1.47

1.1

1.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

118

1.58

1.47

6.1

4.3

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.86

1.47

1.1

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

132

0.49

1.46

1.0

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

316

0.67

1.45

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

619

3643

1.10

1.44

1.4

9.7

9.8

u/l

0.07

504

2939

(3028707) Methadone [Presence] in Urine by Screen method

186

1414

0.85

1.43

3.0

2.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

203

1532

0.85

1.43

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

114

1.58

1.42

1.3

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

221

0.61

1.42

1.0

1.7

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

188

0.58

1.40

1.1

1.2

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

359

1.31

1.39

1.1

1.5

55.6

181.6

titre

—

(3011412) CD3 cells [#/volume] in Blood

307

1742

1.14

1.38

1.8

2.5

1.0

1.1

e9/l

2.61

198

1019

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

115

1.57

1.38

1.3

1.2

44.2

51.2

mg/l

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

376

2713

0.89

1.38

4.3

4.9

338.7

359.6

umol/l

2.30

329

2297

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

273

0.66

1.36

1.3

1.5

—

(3010503) CD19 cells [#/volume] in Blood

212

1173

1.17

1.36

2.0

2.7

0.1

0.4

e9/l

2.39

204

1141

(3023511) Choriogonadotropin [Units/volume] in Urine

498

0.75

1.36

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

691

4101

1.09

1.35

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

181

990

1.18

1.34

1.6

5.6

mmol/24h

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.44

1.32

1.3

1.0

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

102

813

0.81

1.32

1.1

489.6

631.9

ng/l

0.16

202

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

418

2427

1.11

1.30

3.2

3.4

7.1

8.4

nmol/l

0.22

401

2367

(3020717) Zinc [Moles/volume] in Serum or Plasma

138

739

1.20

1.30

1.3

1.5

18.0

26.1

umol/l

3.17

126

699

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

2.58

1.28

1.0

1.1

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.93

1.27

1.0

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

214

1591

0.87

1.27

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

399

2316

1.11

1.26

3.6

3.8

—

(3001186) Copper [Moles/volume] in Serum or Plasma

394

1.28

1.25

1.1

1.2

16.4

16.6

umol/l

0.09

349

(3017732) Neutrophils [#/volume] in Blood

1942

13099

0.95

1.25

3.3

3.0

4.5

4.0

e9/l

5.54

1456

9674

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

108

1.55

1.24

1.0

1.1

41.5

119.4

u/l

0.64

(3002619) Bacteria identified in Specimen by Culture

400

1.27

1.24

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

482

2828

1.10

1.24

1.2

1.3

159.3

204.1

miu/ml

1.38

100

1101

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

254

1.35

1.23

2.6

2.5

72.6

63.9

pmol/l

0.45

222

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

312

0.70

1.23

1.5

2.2

—

(37019676) Renin [Units/volume] in Plasma --supine

1.91

1.22

1.0

84.6

18.5

mu/l

—

(3001729) Color of Synovial fluid

156

1.45

1.22

1.4

1.7

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.84

1.20

1.0

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.47

1.20

2.0

1.6

—

(3036670) Protein [Mass/volume] in Synovial fluid

118

629

1.21

1.19

1.2

1.3

40.7

40.6

g/l

0.03

332

(3016228) CD19 cells/100 cells in Blood

141

766

1.19

1.17

1.9

2.1

7.5

8.4

0.52

136

749

(1175426) CD3 cells/100 lymphocytes in Blood

237

1341

1.14

1.16

1.7

2.1

72.6

71.9

0.32

223

1282

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.44

1.16

1.0

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

105

1.54

1.15

1.4

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

441

0.76

1.15

1.5

1.7

—

(3014271) Vancomycin [Susceptibility]

201

1125

1.15

3.1

2.9

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

198

1107

1.15

2.4

2.8

36.1

37.4

0.37

341

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

27572

178698

0.97

1.15

21.6

13.5

73.7

78.5

ml/min/173m2

239.19

23798

146984

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

256

1863

0.89

1.14

1.3

1.5

—

(3007463) Buprenorphine [Presence] in Urine

2.38

1.13

14.9

7.5

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

531

0.79

1.09

1.5

0.4

ug/l

0.77

341

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

181

1343

0.87

1.09

1.2

1.4

33.8

33.2

u/l

0.07

144

1083

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

2.26

1.09

1.0

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

30750

198952

0.97

1.07

14.1

10.7

28.6

26.5

u/l

15.43

29815

191006

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

289

1.29

1.07

1.1

1.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.92

1.07

1.4

1.0

2.3

2.6

0.20

(1002224) Polysomnography panel

1029

7022

0.94

1.06

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

1.01

0.0

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

135

743

1.17

1.00

1.9

2.3

63.1

54.7

umol/l

1.91

604

(3025296) Carrot IgE Ab [Units/volume] in Serum

0.00

0.99

0.0

1.0

—

0.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

136

750

1.17

0.99

1.9

2.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

151

841

1.16

0.97

1.2

62.4

59.4

0.13

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

230

1320

1.12

0.96

1.7

2.0

16.4

15.2

0.45

536

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

303

0.74

0.94

3.5

3.2

52.9

142.5

ng/l

1.99

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

341

1.25

0.94

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

245

1.29

0.91

1.4

1.6

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

174

0.67

0.91

1.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

139

1.39

0.90

1.3

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

678

0.84

0.89

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

309

1.25

0.89

1.1

—

(3034614) HLA Ag [Interpretation]

1.91

0.89

1.9

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

364

2151

1.09

0.89

3.1

3.5

62.3

58.1

2.68

231

1391

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2479

16494

0.97

0.88

2.3

2.2

12.3

13.1

nmol/l

5.59

2170

14702

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

415

0.79

0.88

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

210

1207

1.12

0.88

1.5

2.0

15.9

16.3

nmol/l

0.32

196

1122

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

409

1.21

0.87

1.1

—

(3036603) Volume of Urine

235

1360

1.11

0.87

1.6

1779.8

1976.7

0.86

306

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

380

1.22

0.87

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.51

0.86

12.7

8.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

179

0.68

0.86

1.3

2.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

189

1082

1.13

0.85

1.5

1.9

—

(3005011) Chlamydia sp Ab [Titer] in Serum

216

0.72

0.84

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

189

1083

1.13

0.84

1.5

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

189

1083

1.13

0.84

1.5

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

189

1083

1.13

0.84

1.5

1.9

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

252

1795

0.90

0.84

1.1

58.5

69.9

au/ml

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.48

0.84

1.1

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

114

853

0.86

0.83

1.1

u/l

0.43

451

(3022475) Manganese [Moles/volume] in Blood

108

0.60

0.83

1.3

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.73

0.82

1.1

1.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.82

0.0

1.1

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.82

0.0

1.1

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.82

0.0

1.0

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.81

0.0

1.7

—

11.4

—

(46235168) Fasting glucose [Moles/volume] in Blood

221

0.73

0.80

1.8

2.3

8.3

7.1

mmol/l

1.50

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.43

0.79

1.0

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

148

839

1.14

0.79

1.5

1.6

10.8

8.5

ug/l

0.36

132

767

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

486

1.18

0.78

1.2

291.8

293.4

pmol/l

0.01

347

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.76

0.77

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

118

873

0.87

0.76

1.2

1.1

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

133

1.36

0.76

1.4

1.8

1.1

0.7

0.23

107

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

248

0.75

0.76

2.0

17.8

17.9

umol/l

0.01

248

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

107

796

0.87

0.75

1.0

1.1

6.6

5.6

u/ml

0.14

119

(3048879) Bone marrow aspiration report

120

674

1.15

0.75

1.5

1.7

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

207

1.28

0.74

1.0

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

102

566

1.16

0.74

1.2

24.9

22.5

0.11

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

156

1.32

0.74

1.2

1.4

0.9

1.1

ml/s/173m2

0.57

105

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.54

0.74

1.1

234.9

290.8

nmol/l

0.67

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

347

1.21

0.73

1.9

3.0

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

166

954

1.12

0.73

1.5

1.4

3.4

4.0

0.24

199

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

112

1.38

0.73

1.8

1.2

0.1

0.2

nmol/l

0.86

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.58

0.72

1.1

1.2

—

(3007733) Chloride [Moles/volume] in Urine

1.61

0.72

1.1

1.2

86.9

78.0

mmol/l

—

(3045142) Bone marrow Pathology biopsy report

395

2369

1.08

0.72

1.3

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.41

0.71

1.3

1.6

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

258

1521

1.09

0.71

1.0

1.1

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

111

0.64

0.71

1.1

1.2

1.3

1.4

1.19

111

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

381

0.81

0.71

4.0

5.3

59.0

52.1

u/l

0.13

141

(3016244) Insulin [Units/volume] in Serum or Plasma

135

769

1.13

0.70

2.2

3.2

26.2

26.0

mu/l

0.02

125

719

(3009015) Lactate [Moles/volume] in Synovial fluid

227

1.25

0.69

1.2

1.3

6.6

6.8

mmol/l

0.11

109

(3042517) Benzodiazepines panel - Urine

1.42

0.68

7.6

2.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

138

1001

0.89

0.68

1.2

1.4

—

(4015189)

108

608

1.15

0.67

2.1

2.3

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.58

0.67

1.0

1.1

—

mmol/l

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.58

0.67

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

1.43

0.67

1.1

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

822

5058

1.05

0.66

5.1

3.9

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

142

815

1.12

0.66

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

188

1.27

0.66

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

220

1294

1.10

0.66

2.6

1.7

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

276

1926

0.92

0.64

1.1

3.2

4.0

u/ml

0.48

797

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

368

2217

1.07

0.62

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

678

4161

1.05

0.62

1.1

12.8

8.1

u/ml

0.43

438

(3021661) Pineapple IgE Ab [Units/volume] in Serum

0.00

0.62

0.0

1.0

—

0.5

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.62

0.0

1.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

709

4357

1.05

0.62

1.4

1.3

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

124

710

1.13

0.62

3.1

3.0

29.6

28.6

umol/l

0.37

546

(3032868) Hemoglobin electrophoresis panel in Blood

137

0.71

0.62

1.5

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

884

5943

0.96

0.61

1.8

1.7

40.6

41.7

nmol/l

0.79

853

5769

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

790

4870

1.05

0.61

1.8

1.7

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.52

0.58

1.3

1.1

—

(3025577) Chromium [Mass/volume] in Blood

232

1379

1.09

0.57

2.1

2.8

2.3

ug/l

0.70

198

1145

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

120

0.70

0.57

1.8

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

107

777

0.89

0.57

1.4

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.55

0.57

1.2

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.55

0.57

1.0

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.68

0.57

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

15379

98436

1.01

0.56

2.5

2.4

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

178

0.76

0.56

1.2

1.1

0.0

0.6

u/ml

1.44

115

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

164

1.26

0.56

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

369

0.84

0.55

6.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

235

0.80

0.55

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

141

0.73

0.55

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.37

0.54

1.0

—

(3004616) Nuclear Ab [Presence] in Serum

381

2314

1.06

0.54

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

492

0.86

0.53

1.2

1.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.66

0.53

1.3

1.0

7.5

8.7

mmol/l

—

(3041184) Isoniazid [Presence] in Urine

1.55

0.53

3.0

2.7

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

1.55

0.53

1.8

3.0

1.8

1.5

mu/l

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.37

0.52

1.0

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

200

1188

1.09

0.52

1.2

1.3

1.8

1.2

u/ml

0.33

102

612

(3000060) B lymphocytes [#/volume] in Blood

415

0.85

0.52

1.4

1.9

493.2

1257.0

e6/l

0.51

213

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

195

1.22

0.52

1.1

1.0

106.6

84.9

ug/l

1.13

145

(3003338) MCHC [Mass/volume]

23750

152483

1.01

0.52

30.7

18.4

331.3

332.6

g/l

86.77

23553

151451

(3038026) Centromere Ab [Units/volume] in Serum

260

1562

1.07

0.51

1.3

1.2

59.1

54.4

u/ml

0.07

(3020393) Adenovirus Ag [Presence] in Stool

161

1.24

0.50

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

387

1.15

0.50

1.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

419

2560

1.06

0.50

1.3

1.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

253

1521

1.07

0.50

1.3

1.2

39.1

40.1

u/ml

0.03

111

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.56

0.49

1.0

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

266

0.82

0.49

8.4

7.5

1.3

0.3

umol/l

0.63

244

(44806420)

571

1.12

0.48

2.1

2.4

—

(3026470) Cobalt [Mass/volume] in Blood

237

1425

1.07

0.47

2.0

5.0

3.5

ug/l

1.11

210

1248

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

251

1.18

0.47

2.3

2.7

0.5

0.6

u/field

0.17

251

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

222

1.19

0.46

2.2

2.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.41

0.45

1.0

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

1.45

0.45

1.3

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

205

1.20

0.44

1.7

1.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.68

0.44

1.6

1.5

—

(3015350) Toxocara sp Ab [Presence] in Serum

1.61

0.43

1.0

—

(40758358) Immune stain study

0.71

0.43

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.42

0.0

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.42

0.0

1.1

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.42

0.0

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

412

1.13

0.41

1.5

2.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.42

0.41

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

316

0.86

0.41

1.1

1.2

—

(3013862) HLA-DP [Type]

0.67

0.40

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

232

0.83

0.40

1.3

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

250

1518

1.06

0.40

1.2

62.5

86.9

u/ml

0.54

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.47

0.40

1.6

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

7009

45627

0.99

0.40

2.8

3.0

0.7

0.8

ug/l

1.85

4795

29980

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

125

1.24

0.40

1.7

1.3

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

238

1444

1.06

0.39

1.3

1.2

2.7

5.5

u/ml

—

(3020874) Milk IgE Ab [Units/volume] in Serum

661

0.91

0.39

1.0

0.7

0.8

u/ml

0.08

189

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

408

1.12

0.39

1.2

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

687

4582

0.97

0.38

1.3

551.2

578.6

mg/l

0.38

646

4355

(3036071) Salmonella sp Ab [Titer] in Serum

470

1.11

0.38

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.70

0.38

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

237

0.84

0.38

1.2

1.1

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

138

1.21

0.37

1.5

39.8

40.3

0.02

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.49

0.37

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

490

1.11

0.36

1.1

1.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

605

4038

0.97

0.36

1.2

4.2

3.8

mmol/l

9.23

560

3798

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

210

1.17

0.36

1.2

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

121

1.23

0.36

2.3

2.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

175

1204

0.94

0.35

1.2

1.1

42.7

46.8

mg/l

0.60

138

1011

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.31

0.35

1.0

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

130

0.79

0.35

1.1

0.0

0.7

u/ml

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.33

0.34

1.2

1.3

2.1

2.2

mmol/24h

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

230

1.15

0.33

2.2

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

143

860

1.07

0.33

1.6

2.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

143

0.81

0.33

1.0

1.1

—

(40768443) Skin Pathology biopsy report

1406

8879

1.02

0.33

1.2

—

(3006245) CD3-CD19+ cells/100 cells in Blood

587

1.09

0.32

1.5

2.1

8.6

10.3

0.75

531

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

143

861

1.07

0.32

1.6

2.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.29

0.32

1.0

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

701

4388

1.03

0.32

1.9

194.2

203.2

pmol/l

1.49

660

4156

(3021387) Prolactin [Units/volume] in Serum or Plasma

532

3316

1.03

0.32

1.8

295.9

296.7

mu/l

0.01

484

3074

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

201

1.15

0.32

2.1

2.4

—

(40763590) HLA-DQ beta [Type]

0.71

0.31

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.69

0.31

1.0

—

(40760409) HLA-A [Type] by High resolution

0.69

0.31

1.0

—

(40760410) HLA-B [Type] by High resolution

0.69

0.31

1.0

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

1.25

0.31

1.5

1.2

1.5

mg/l

0.19

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

122

844

0.93

0.31

1.1

1.2

—

(3024316) Viscosity of Plasma

100

1.22

0.30

1.5

2.2

1.6

1.8

mpas

0.89

(3047007) Chlamydophila sp Ab [Presence] in Serum

352

2180

1.04

0.30

1.3

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

148

0.83

0.30

2.5

2.7

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

169

1154

0.94

0.29

1.1

311.2

317.9

mg/l

0.12

138

1026

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.34

0.29

1.0

1.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

486

1.09

0.28

1.2

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

144

873

1.06

0.28

1.6

2.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

206

1396

0.95

0.28

1.9

2.6

556.6

702.6

e6/l

0.84

577

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

161

1098

0.95

0.28

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

651

4091

1.03

0.26

4.4

3.3

27.3

27.9

mg/l

0.14

438

2532

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

236

1.12

0.25

1.6

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

453

1.08

0.24

1.2

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

110

0.82

0.24

1.3

1.2

—

(44806071)

213

0.88

0.24

1.2

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.81

0.24

1.0

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

198

1219

1.05

0.24

1.6

2.6

441.2

564.7

e6/l

2.19

163

1033

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

200

1.13

0.24

1.2

1.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

597

1.07

0.24

1.4

2.0

32.8

30.2

0.73

555

(3012494) Peanut IgE Ab [Units/volume] in Serum

307

0.90

0.23

1.1

1.0

0.4

0.9

u/ml

1.00

154

(40768441) Liver Pathology biopsy report

217

1459

0.96

0.23

1.4

—

(3018291) Platelet Ab [Presence] in Serum

1.29

0.23

1.0

1.1

—

(40758292) HTLV I+II Ab panel - Serum

313

0.91

0.23

1.2

1.5

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.25

0.23

1.1

1.0

—

(3013762) Body weight Measured

1.23

0.22

1.1

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

518

1.07

0.22

1.2

144.0

130.3

nmol/l

0.23

367

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.20

0.22

1.5

2.0

mg/l

0.00

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

1.20

0.22

1.5

1.2

3.6

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

1.20

0.22

1.5

3.4

1.7

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

1.20

0.22

1.5

1.6

1.3

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

1.20

0.22

1.5

0.3

1.1

mg/l

1.20

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.22

0.0

1.3

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.1

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.22

0.0

1.1

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.3

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.3

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

158

1067

0.95

0.21

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.29

0.21

1.2

1.1

—

(3002719) Hemoglobin [Mass/volume] in Urine

1.29

0.21

1.0

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

215

1.11

0.21

14.6

8.7

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

339

1.08

0.20

1.8

1.6

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

1.19

0.20

1.1

1.0

0.3

0.2

u/ml

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

713

4688

0.98

0.20

2.5

3.5

1606.5

615.9

u/ml

0.58

646

4266

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

232

1443

1.04

0.20

1.2

1.3

2.2

mmol/l

0.09

216

1344

(4027681)

139

855

1.05

0.19

1.3

1.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

110

673

1.05

0.19

1.7

1.4

1924160.0

2220930.2

iu/ml

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

608

0.94

0.19

1.9

3.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

291

1.09

0.19

1.2

—

(3020650) Glucose [Presence] in Urine

442

0.93

0.19

1.5

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

355

0.93

0.18

1.5

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

771

4885

1.02

0.18

1.3

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

214

0.90

0.17

1.0

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.84

0.17

1.0

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

154

954

1.04

0.17

1.0

1.1

10.1

10.0

iu/ml

0.03

202

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1484

9678

0.99

0.17

1.2

124.1

135.9

iu/ml

0.54

555

3458

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

187

1164

1.04

0.16

1.6

2.7

0.2

e9/l

0.35

165

1022

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

152

0.89

0.16

1.5

1.7

1.6

1.7

mg/l

0.23

119

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.20

0.16

1.1

1.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

345

0.93

0.15

2.1

1.7

1.9

2.6

ug/l

1.13

203

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.12

0.15

1.1

1.0

2.6

0.2

u/ml

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

411

0.94

0.15

2.6

2.4

155.3

175.8

au/ml

0.13

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

185

0.91

0.15

1.1

1.0

—

(3049242) von Willebrand panel - Platelet poor plasma

0.79

0.15

2.6

1.6

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

131

0.89

0.14

1.7

1.5

0.6

0.7

umol/l

—

102

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

609

3991

0.98

0.14

1.3

1.4

1139.2

1954.6

e6/l

0.68

511

3208

(4133840)

516

1.05

0.14

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

241

1513

1.03

0.14

1.0

726.9

735.2

ng/l

0.11

157

1038

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

134

1.11

0.13

1.1

1.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

241

1515

1.03

0.13

1.0

41.0

43.3

ng/l

0.30

156

1068

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

103

0.88

0.13

1.0

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

609

3985

0.98

0.13

1.3

1.4

13.3

34.5

e6/l

2.93

476

3027

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

524

1.05

0.13

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

123

0.89

0.13

1.1

14.4

15.2

nmol/l

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

480

1.05

0.13

1.4

1.2

2.0

3.0

umol/l

4.35

443

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

447

0.95

0.12

2.9

3.0

6.8

7.6

mg/l

0.42

356

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

296

1948

0.98

0.12

1.9

2.0

577.8

2763.6

titre

—

110

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

129

1.10

0.11

1.0

—

(4198724)

459

0.95

0.11

1.7

1.9

—

(3033942) Copper [Moles/time] in 24 hour Urine

1.16

0.11

1.1

0.5

0.8

umol/24h

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.16

0.11

1.0

—

(4212803)

198

1.07

0.11

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

360

0.95

0.11

1.1

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

145

908

1.03

0.11

1.2

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

189

1189

1.02

0.11

1.7

—

(21494815) CD4 cells/100 lymphocytes in Specimen

245

1612

0.98

0.10

1.8

2.2

45.2

37.4

1.58

198

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

121

0.91

0.10

1.1

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

1.15

0.10

1.4

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1233

7884

1.01

0.10

1.1

1.0

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

238

1504

1.02

0.10

1.0

299.5

329.4

ng/l

0.93

155

1076

(36303858) Crystals [Presence] in Urine

1.07

0.09

1.0

1.2

—

(40762814) Titanium [Mass/volume] in Blood

422

1.04

0.09

2.2

2.3

3.4

3.9

ug/l

0.53

149

(40765096) Chromosome analysis panel by Banding

625

0.97

0.09

1.1

1.2

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

1.05

0.08

1.0

1.1

0.2

g/l

—

(40762887) Creatinine [Moles/volume] in Blood

1.03

0.08

1.1

1.2

—

(3001556) Androgen free Index in Serum or Plasma

0.82

0.07

1.3

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

178

0.94

0.07

1.1

1.0

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

278

1.04

0.07

1.3

1.4

42.2

52.9

0.84

128

(3022725) Serotonin [Moles/volume] in Serum

1.05

0.07

1.4

1.5

616.8

995.7

nmol/l

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

135

852

1.02

0.07

1.3

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

295

1927

0.99

0.07

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

158

1038

0.98

0.07

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.02

0.07

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

431

1.03

0.07

1.2

96.3

56.5

mu/l

1.07

308

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

222

1.05

0.06

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

222

1.05

0.06

1.1

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

451

0.97

0.06

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

146

1.06

0.06

1.3

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.92

0.05

1.0

1.5

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

441

2820

1.01

0.05

2.5

168.3

1067.8

u/ml

1.47

432

2780

(3027570) Oxalate [Moles/time] in 24 hour Urine

109

1.06

0.04

1.6

1.3

302.1

359.6

umol/24h

0.70

109

(3029396) Erythrocyte agglutination [Presence] in Blood

1.07

0.04

1.1

1.9

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

493

1.02

0.04

1.2

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

115

732

1.01

0.03

1.2

1.1

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.06

0.03

1.1

1.3

1.0

1.1

u/field

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

283

1.03

0.03

1.4

2.3

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

359

2327

0.99

0.02

1.1

11.8

12.0

au/ml

—

121

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

297

0.98

0.02

1.2

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

232

0.97

0.02

1.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.93

0.02

1.0

0.0

0.2

u/ml

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

225

0.97

0.02

1.2

1.3

11.0

9.4

mmol/l

0.64

116

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

199

0.97

0.02

4.2

5.6

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1209

7805

1.00

0.01

2.9

3.6

3178.3

1209.0

u/ml

0.42

1015

6745

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.06

0.01

1.0

1.6

—

(4024509)

311

1998

1.00

0.01

1.6

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

172

0.97

0.01

1.0

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.95

0.01

1.1

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

124

804

0.99

0.00

1.1

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

138

1.03

0.00

2.6

3.0

22.1

77.4

pmol/l

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

100

0.97

0.00

1.4

1.6

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

224

1.01

0.00

4.7

2.6

1.0

1.2

mg/l

0.60

161

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

274

1.01

0.00

1.3

1.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

499

0.99

0.00

1.2

1.1

—

(3017509) Phencyclidine [Presence] in Urine

113

1.03

0.00

1.2

1.5

—

(3018001) Oat IgE Ab [Units/volume] in Serum

0.98

0.00

1.1

0.1

0.4

u/ml

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

222

1.02

0.00

1.1

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

171

0.98

0.00

1.1

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.99

0.00

1.0

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

210

1.01

0.00

1.0

1.1

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

374

1.00

0.00

2.6

2.8

630.2

1852.3

u/l

1.18

331

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

1.00

0.00

1.0

33.0

22.0

u/ml

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

494

1.00

0.00

1.2

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

321

1.00

0.00

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.94

0.00

1.0

1.1

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

4.9

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.97

0.00

1.3

434.3

552.6

nmol/l

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.94

0.00

1.0

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

0.00

0.0

1.6

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.0

1.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.0

1.0

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.0

2.0

—

(3006392) Corynebacterium diphtheriae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

0.90

0.00

1.2

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_CORATHER and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_CORATHER	1.931 [1.79, 2.09]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.001

During the follow-up period (1.1.1998 — 31.12.2019), 89079 out of 166934 females with I9_CORATHER died.

Males

Parameter	HR [95% CI]	p-value
I9_CORATHER	1.649 [1.53, 1.78]	< 0.001
Birth year	0.987 [0.98, 0.99]	0.001

During the follow-up period (1.1.1998 — 31.12.2019), 96810 out of 219429 males with I9_CORATHER died.

Mortality risk

Mortality risk for people of age

years, who have I9_CORATHER.

N-year risk	Females	Males
1	0.111%	0.214%
5	0.798%	1.488%
10	2.045%	3.61%
15	3.793%	7.058%
20	6.181%	11.9%

Relationships between endpoints

↥

Index endpoint: I9_CORATHER – Coronary atherosclerosis

GWS hits: 147

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Coronary atherosclerosis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints